Budesonide

RX_A07EA

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — A07EA 1 out of 7 registries used, show all original rules.	6083
4. Check minimum number of events Min. number of events 3	6083
5. Include endpoints None	6083
6. Filter based on genotype QC (FinnGen only)	6083

Control definitions (FinnGen only)

Control exclude: IBD_DRUGS

Extra metadata

First used in FinnGen datafreeze: DF4

NAME	RX_A07EA
CONTROL_EXCLUDE	IBD_DRUGS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	A07EA
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Budesonide based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6083	3732	2351
Unadjusted period prevalence (%)	1.18	1.27	1.04
Median age at first event (years)	46.36	44.83	48.81

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5287: Matched controls
52869

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

5.9

323.0

2674

7771

L04AX01

ATC

azathioprine; systemic

954.4

323.0

2425

A07EA06

ATC

budesonide; oral, local oral

1448.6

323.0

4134

126

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

423.5

323.0

1071

A07EA01

ATC

prednisolone; rectal

842.6

323.0

532

K51.5

ICD-10 Finland

Left sided colitis

621.1

323.0

2014

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

1189.9

323.0

630

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1977.6

323.0

3703

H02AB06

ATC

prednisolone; systemic

11.7

323.0

3998

11106

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

4.4

323.0

2328

7944

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

49.4

323.0

947

232

UJF92

NOMESCO Finland

Capsular endoscopy

23.5

323.0

497

232

UJF30

NOMESCO Finland

Ileoscopy through colon

19.1

323.0

2171

1860

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

98.7

323.0

359

P01AB01

ATC

metronidazole; oral, rectal

3.4

323.0

2860

13691

L04AB04

ATC

adalimumab; parenteral

119.2

323.0

497

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

9.3

323.0

1259

1713

A07EC02

ATC

mesalazine; oral, rectal

756.9

323.0

3825

182

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

474.6

323.0

669

K51

ICD-10 Finland

Ulcerative colitis

302.9

323.0

543

J01MA02

ATC

ciprofloxacin; systemic

3.5

323.0

2694

12064

L01BB02

ATC

mercaptopurine; oral

1255.9

323.0

755

A07EC01

ATC

sulfasalazine; oral, rectal

45.1

323.0

1192

339

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

497.6

323.0

499

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

937.9

323.0

1491

UJF32

NOMESCO Finland

Coloscopy

15.8

323.0

3616

6362

H02AB07

ATC

prednisone; oral

10.9

323.0

1806

2393

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

11.9

323.0

726

697

K50.0

ICD-10 Finland

Crohn disease of small intestine

175.0

323.0

1007

D94

ICPC

Chronic enteritis/ulcerative colitis

246.8

323.0

410

K50.1

ICD-10 Finland

Crohn disease of large intestine

401.1

323.0

749

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

16.6

323.0

780

545

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

268.2

323.0

1929

113

A06AC01

ATC

ispaghula (psylla seeds); oral

3.7

323.0

1866

6799

K50.9

ICD-10 Finland

Crohn disease, unspecified

240.3

323.0

915

K50.8

ICD-10 Finland

Other Crohn disease

402.6

323.0

1030

K51.8

ICD-10 Finland

Other ulcerative colitis

395.9

323.0

827

A07EA02

ATC

hydrocortisone; rectal

732.7

323.0

2496

C10AC01

ATC

colestyramine; oral

19.4

323.0

622

360

ZX120

NOMESCO Finland

Intravenous

6.1

322.5

970

1870

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

9.4

310.7

684

826

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

147.5

289.1

306

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.9

274.5

2500

12489

A02BC02

ATC

pantoprazole; systemic

2.9

269.1

3687

23610

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

56.3

258.4

308

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

7.1

225.7

593

928

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

77.3

220.0

250

A07EC03

ATC

olsalazine; oral

2068.4

217.0

209

4AA12

NOMESCO Finland

419.4

203.6

203

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

3.2

199.7

1254

4672

TPH04

NOMESCO Finland

Cathetrisation of vein

3.1

199.2

1368

5424

K50

ICD-10 Finland

Crohn disease [regional enteritis]

255.6

193.1

197

4AB02

NOMESCO Finland

474.0

185.3

184

WX002

NOMESCO Finland

Sedation and analgesia

2.9

178.3

1303

5328

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

+∞

178.1

170

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

95.9

175.4

194

JFH30

NOMESCO Finland

Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy

586.9

173.3

171

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

4.0

161.6

716

1987

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

190.3

159.7

166

5561A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis

171.3

158.5

166

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

82.8

156.4

176

A05AA02

ATC

ursodeoxycholic acid; oral

13.1

150.3

273

219

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.2

147.5

2087

11972

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.5

147.0

778

2494

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

9.8

144.3

304

328

N02AX02

ATC

tramadol; systemic, rectal

2.1

139.1

2226

13392

H02AB04

ATC

methylprednisolone; systemic

3.2

138.7

825

2876

K59.1

ICD-10 Finland

Functional diarrhoea

5.0

135.5

465

994

L04AD01

ATC

ciclosporin; systemic

16.6

133.6

219

137

A07DA03

ATC

loperamide; oral

6.4

131.1

363

598

L04AC05

ATC

ustekinumab; parenteral

83.5

129.9

146

56310

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Ulcerative colitis

66.1

127.6

148

H02AB09

ATC

hydrocortisone; systemic

10.0

126.1

261

272

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

3.0

125.9

834

3117

JF1BD

NOMESCO Finland

Very extensive small bowel CT

32.1

125.9

168

A02BC03

ATC

lansoprazole; oral

2.3

125.4

1563

8302

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

5.2

122.5

405

828

A02BC05

ATC

esomeprazole; systemic

2.1

122.5

2157

13294

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.9

122.3

826

3123

Z01.8

ICD-10 Finland

Other specified special examinations

2.3

114.5

1246

6154

5568X

ICD-9 Finland

Idiopathic proctocolitis, Other ulcerative colitis

112.6

111.4

121

5562A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctitis

96.1

110.5

122

M07.4*K50.9

ICD-10 Finland

Arthropathy in Crohn's disease [regional enteritis]

543.9

108.2

107

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

5.5

105.6

333

643

A06AC51

ATC

ispaghula, combinations; systemic

4.4

104.9

412

1005

L04AB06

ATC

golimumab; parenteral

160.4

104.6

110

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

27.1

100.6

140

K75.4

ICD-10 Finland

Autoimmune hepatitis

502.2

99.8

C05AA08

ATC

fluocortolone; rectal, topical

2.5

99.3

878

3860

N02BE01

ATC

paracetamol; systemic, rectal

2.1

98.4

4415

37217

4AA33

NOMESCO Finland

955.5

96.3

K62.8

ICD-10 Finland

Other specified diseases of anus and rectum

16.1

93.3

154

3042

Kela drug reimbursment

903.7

91.1

B03BA03

ATC

hydroxocobalamin; parenteral

4.1

90.9

375

956

253

Kela drug reimbursment

893.4

90.0

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.9

89.9

396

1071

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

5.7

89.6

272

501

N02AJ06

ATC

codeine and paracetamol; systemic

1.9

88.8

1947

12582

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.6

88.7

438

1304

K74.3

ICD-10 Finland

Primary biliary cirrhosis

26.8

88.2

123

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

7.7

85.7

207

279

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

83.3

1428

8395

J01MA12

ATC

levofloxacin; systemic

2.3

83.3

925

4528

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

19.5

82.0

126

A02BC01

ATC

omeprazole; systemic

2.0

81.1

1356

7883

L04AA01

ATC

[U] ciclosporin; systemic

18.7

80.8

126

D11

ICPC

Diarrhoea

2.5

80.4

723

3179

R50.9

ICD-10 Finland

Fever, unspecified

2.4

80.4

766

3470

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

19.9

79.4

121

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

7.1

78.8

201

294

1370

FHL

Colonoscopy, whole colon

23.3

78.6

114

Z93.2

ICD-10 Finland

Ileostomy status

40.4

78.4

K83.0

ICD-10 Finland

Cholangitis

10.6

78.3

156

151

JF1AD

NOMESCO Finland

Small bowel CT

24.9

77.4

110

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

76.7

2302

16242

M05BA04

ATC

alendronic acid; oral

3.6

75.1

369

1090

M45

ICD-10 Finland

Ankylosing spondylitis

10.3

75.1

152

3AC01

NOMESCO Finland

12.0

74.7

140

120

JFH33

NOMESCO Finland

Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy

738.5

74.4

E0000UV

ATC

1.8

74.2

1984

13466

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

4.5

73.7

278

648

J01DB01

ATC

cefalexin; oral

1.8

73.6

4207

35842

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

11.7

72.8

138

121

P01BA02

ATC

hydroxychloroquine; oral

4.2

72.3

290

718

3005

Kela drug reimbursment

Tofacitinib

707.7

71.3

M07.5

ICD-10 Finland

Arthropathy in ulcerative colitis

+∞

71.0

N03AX16

ATC

pregabalin; oral

2.0

69.9

1146

6554

L88

ICPC

Rheumatoid/seropositive arthritis

9.0

69.7

152

174

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

3.8

68.4

313

871

A03CA02

ATC

clidinium and psycholeptics; oral

3.4

68.2

355

1096

J01FA10

ATC

azithromycin; systemic

1.7

67.8

2976

23097

JFB00

NOMESCO Finland

Partial resection of small intestine

7.9

67.6

159

206

JFA38

NOMESCO Finland

Endoscopic dilatation of small intestine

656.3

66.1

5560A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) enterocolitis

141.8

66.0

JFB20

NOMESCO Finland

Ileocaecal resection

18.4

65.9

103

A07AA09

ATC

vancomycin; oral

9.9

65.2

134

138

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.1

64.8

791

3999

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.0

63.0

394

1385

L04AA29

ATC

tofacitinib; oral

615.2

61.9

A02BA02

ATC

ranitidine; systemic

2.0

61.7

916

5013

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

61.2

1840

12724

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

61.1

688

3347

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

5.7

60.5

180

323

N05CF01

ATC

zopiclone; oral

1.7

60.4

1494

9743

J02AC01

ATC

fluconazole; systemic

1.6

60.1

2044

14612

UJG02

NOMESCO Finland

Proctoscopy

5.5

59.9

184

343

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.5

59.1

525

2273

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

41.0

58.3

JFH10

NOMESCO Finland

Total colectomy and ileostomy

42.9

58.0

5552A

ICD-9 Finland

Regional enteritis, Small intestine with large intestine

295.1

57.4

D07AC01

ATC

betamethasone; topical

1.7

57.2

1600

10792

R03AC02

ATC

salbutamol; inhalant

1.6

57.0

2452

18563

K60.3

ICD-10 Finland

Anal fistula

6.1

56.7

160

269

JFH20

NOMESCO Finland

Proctocolectomy and ileostomy

289.8

56.3

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.5

55.7

478

2029

B01AB05

ATC

enoxaparin; parenteral

1.7

55.3

1371

8906

UJF02

NOMESCO Finland

Peroral enteroscopy

14.2

55.1

J05AB11

ATC

valaciclovir; oral

2.1

54.4

674

3412

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

4.7

54.4

191

414

JFH11

NOMESCO Finland

Laparoscopic colectomy

279.1

54.3

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.3

54.0

293

931

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.9

54.0

865

4847

J01AA02

ATC

doxycycline; systemic

1.6

53.7

3754

31861

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.4

53.6

518

2334

R01AD09

ATC

mometasone; nasal

1.6

53.6

2197

16339

J01FA06

ATC

roxithromycin; oral

1.6

53.4

1865

13308

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.0

53.2

724

3809

B81

ICPC

Anaemia vit B12/folate deficiency

4.0

53.0

224

581

JN3AD

NOMESCO Finland

Abdominal CT examination

2.6

52.7

413

1666

N06AX11

ATC

mirtazapine; oral

1.7

52.4

1550

10562

JFF10

NOMESCO Finland

Loop enterostomy

14.1

51.6

R01AD08

ATC

fluticasone; nasal

1.7

51.3

1348

8869

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

8.4

51.2

115

139

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

3.2

51.1

291

958

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

51.0

1034

6279

JX1LA

NOMESCO Finland

Kinetic X-ray of alimentary tract with pictures

32.3

50.8

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

6.9

50.5

130

193

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

5.7

50.2

149

267

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

16.9

49.8

JHA00

NOMESCO Finland

Anal or perianal incision

6.7

49.4

129

196

M35.3

ICD-10 Finland

Polymyalgia rheumatica

7.4

48.7

119

164

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

48.7

890

5210

L04AA33

ATC

vedolizumab; parenteral

482.2

48.4

K76.9

ICD-10 Finland

Liver disease, unspecified

7.1

47.4

119

171

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.3

47.3

492

2295

A07AA02

ATC

nystatin; oral

2.9

46.8

301

1074

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.4

46.8

175

405

M25.5

ICD-10 Finland

Pain in joint

1.7

46.7

1329

8901

K92.1

ICD-10 Finland

Melaena

3.1

46.5

267

883

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

27.0

46.4

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.4

46.3

434

1920

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.5

46.2

230

685

K61.0

ICD-10 Finland

Anal abscess

5.6

44.9

136

250

JGB50

NOMESCO Finland

Mucosal proctectomy and ileoanal anastomosis

121.1

44.8

K56.7

ICD-10 Finland

Ileus, unspecified

6.0

44.2

126

215

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.9

44.2

189

496

J05AB01

ATC

aciclovir; systemic

1.7

44.0

1000

6259

K51.4

ICD-10 Finland

Inflammatory polyps

+∞

43.8

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

43.7

704

3928

D07AB02

ATC

hydrocortisone butyrate; topical

1.6

43.3

1308

8873

A01AB09

ATC

miconazole; local oral

2.4

43.0

407

1807

5550A

ICD-9 Finland

Regional enteritis, Small intestine

116.0

42.8

N05BA04

ATC

oxazepam; oral

1.7

42.7

1159

7630

107

Kela drug reimbursment

Pernicious anaemia

5.5

42.7

131

245

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

9.8

42.5

D07AC13

ATC

mometasone; topical

1.6

42.3

1331

9116

M03BX02

ATC

tizanidine; oral

1.5

42.3

3030

25059

S18

ICPC

Laceration/cut

1.5

42.1

1836

13615

M13.9

ICD-10 Finland

Arthritis, unspecified

2.8

42.0

286

1058

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.3

41.8

410

1853

TJF80

NOMESCO Finland

Ostomy education

8.2

41.7

118

56300

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Regional enteritis

50.4

41.7

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.5

41.6

360

1528

N06AX21

ATC

duloxetine; oral

2.1

40.8

529

2708

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

6.4

40.3

109

174

UJD02

NOMESCO Finland

Gastroscopy

3.0

40.3

248

860

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

40.2

789

4703

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

24.0

40.1

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

5.9

40.0

115

199

RD210

NOMESCO Finland

5.2

39.8

126

245

K90.0

ICD-10 Finland

Coeliac disease

3.5

39.5

193

567

N03AX12

ATC

gabapentin; oral

1.9

39.4

673

3824

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

7.3

39.3

133

WVA20

NOMESCO Finland

Medicine administration

4.5

39.3

145

332

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

39.1

2150

16700

R03DC03

ATC

montelukast; oral

1.9

39.0

613

3381

D06BX01

ATC

metronidazole; topical

2.0

38.7

520

2703

M07.4

ICD-10 Finland

Arthropathy in Crohn disease [regional enteritis]

+∞

38.6

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.4

38.5

337

1439

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

5.2

38.0

122

241

J01FA09

ATC

clarithromycin; systemic

1.5

37.9

1445

10322

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

37.2

37.8

J01DA01

ATC

[U] cefalexin; systemic

1.5

37.6

2990

24958

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.6

37.5

286

1132

D16

ICPC

Rectal bleeding

4.3

37.2

142

336

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

37.2

496

2566

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

19.5

36.9

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

36.8

800

4914

H04.10

ICD-10 Finland

Dry eye syndrome

2.1

36.8

444

2205

R03BA05

ATC

fluticasone; inhalant

1.8

36.7

761

4605

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

36.7

769

4669

E000001

ATC

1.7

36.6

943

6088

J01MA14

ATC

moxifloxacin; systemic

2.3

36.6

363

1651

D01

ICPC

Abdominal pain/cramps general

2.0

36.4

540

2910

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

3.2

36.3

202

654

M81.4

ICD-10 Finland

Drug-induced osteoporosis

41.2

36.2

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.3

36.1

189

585

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

5.6

36.1

108

197

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.0

35.6

478

2477

M79.6

ICD-10 Finland

Pain in limb

1.5

35.6

1578

11636

M01AH01

ATC

celecoxib; oral (coxibs)

1.7

35.6

765

4680

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.1

35.5

446

2250

L04AA13

ATC

leflunomide; oral

13.3

35.3

1490

FHL

Sigmoideoscopy (fiberscope)

18.8

35.2

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

13.7

35.2

D07AD01

ATC

clobetasol; topical

1.8

35.2

694

4131

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

5.7

35.0

103

184

N05CF02

ATC

zolpidem; oral

1.7

34.8

844

5344

L04AA06

ATC

mycophenolic acid; systemic

6.0

34.6

163

JFB33

NOMESCO Finland

Other resection comprising small intestine and colon

25.5

34.4

R06AE07

ATC

cetirizine; oral

1.5

34.4

2014

15715

R03BA02

ATC

budesonide; inhalant

1.8

34.3

708

4270

R4110

NOMESCO Finland

Physiotherapy

1.6

34.1

1152

7964

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.8

34.0

229

842

J01CA04

ATC

amoxicillin; systemic

1.5

34.0

4000

35723

R11

ICD-10 Finland

Nausea and vomiting

2.2

33.9

381

1834

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

33.7

1023

6880

R03BB04

ATC

tiotropium bromide; inhalant

2.4

33.7

292

1240

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

24.9

33.5

J45.1

ICD-10 Finland

Nonallergic asthma

2.7

33.4

235

886

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

32.9

1878

14541

JFG73

NOMESCO Finland

Excision of ileal pelvic pouch

329.1

32.9

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

7.9

32.7

UJH02

NOMESCO Finland

Anoscopy

2.7

32.6

227

852

D64.9

ICD-10 Finland

Anaemia, unspecified

2.1

32.4

381

1867

R01AD12

ATC

fluticasone furoate; nasal

1.5

32.3

1385

10092

5551A

ICD-9 Finland

Regional enteritis, Large intestine

+∞

32.3

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

32.3

1803

13886

UJF34

NOMESCO Finland

Left colonoscopy

9.3

32.0

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.5

31.9

270

1131

JFF13

NOMESCO Finland

Terminal enterostomy

26.1

31.8

JAH00

NOMESCO Finland

Laparotomy

3.6

31.7

150

430

K29.3

ICD-10 Finland

Chronic superficial gastritis

3.3

31.6

164

505

R06.0

ICD-10 Finland

Dyspnoea

1.6

31.6

934

6223

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.3

31.5

320

1467

WW200

NOMESCO Finland

Immunization

3.4

31.2

157

473

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

6.9

30.8

115

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.3

30.7

161

500

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

5.3

30.5

182

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

30.3

2341

19098

N02AA05

ATC

oxycodone; systemic

1.8

30.2

523

2973

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.7

30.2

220

848

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

30.2

967

6570

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

30.1

1001

6867

JFB21

NOMESCO Finland

Laparoscopic ileocaecal resection

24.9

30.0

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

30.0

702

4386

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

29.9

1511

11363

JF1CM

NOMESCO Finland

Small bowel extensive MRI with with high intensity magnet

68.3

29.9

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

29.5

557

3256

E86

ICD-10 Finland

Volume depletion

4.0

29.0

119

303

56902

ICD-8 Finland

Other diseases of intestines and peritoneum, Proctitis haemorrhagica (ulcerosa)

66.3

28.9

C03CA01

ATC

furosemide; systemic

1.6

28.9

895

6022

K62.7

ICD-10 Finland

Radiation proctitis

11.9

28.8

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

28.8

1344

9925

WX402

NOMESCO Finland

General anaesthesia

1.6

28.7

751

4837

UJK12

NOMESCO Finland

Peroral cholangioscopy

18.5

28.7

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

10.5

28.6

UKC02

NOMESCO Finland

Cystoscopy

1.7

28.4

605

3671

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

28.3

1284

9424

C05AA01

ATC

hydrocortisone; rectal, topical

2.4

28.3

256

1111

M09.2*K51.9

ICD-10 Finland

Juvenile arthritis in ulcerative colitis

+∞

28.1

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.2

28.1

311

1482

R51.80

ICD-10 Finland

Headache

1.7

28.0

666

4174

R06AX27

ATC

desloratadine; oral

1.5

28.0

1228

8948

JF1DM

NOMESCO Finland

Very extensive MRI of small bowel (more than 1.5 T)

64.3

27.9

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.1

27.8

348

1750

WX110

NOMESCO Finland

Local anesthesy

1.4

27.3

3330

29160

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.7

27.3

192

726

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

26.9

1202

8777

D18

ICPC

Change in faeces/bowel movements

3.7

26.9

119

324

TPH07

NOMESCO Finland

Cathetrisation of artery

1.9

26.8

403

2176

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.5

26.6

218

897

A02BC04

ATC

rabeprazole; oral

1.9

26.5

385

2052

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

5.7

26.4

137

C07AB07

ATC

bisoprolol; oral

1.4

26.4

1761

13884

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

26.3

405

2204

SPAT1325

SPAT

Vaccination

1.4

26.2

1391

10507

R03BA01

ATC

beclometasone; inhalant

1.8

26.2

520

3085

K52.0

ICD-10 Finland

Gastroenteritis and colitis due to radiation

16.3

26.2

A98

ICPC

Health maint/preventive medicine

1.9

26.1

5012

47923

L01BB01

ATC

+∞

26.1

ZX112

NOMESCO Finland

Subcutaneous

3.7

25.9

117

324

M02AA07

ATC

piroxicam; topical

1.4

25.7

1511

11623

5586X

ICD-9 Finland

Other non-infective gastro-enteritis and colitis[KROONINEN INFLAMMATOORINEN SUOLISTOSAIRAUS, NUD]

261.9

25.7

J45

ICD-10 Finland

Asthma

2.0

25.7

336

1719

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.0

25.6

333

1701

UJK02

NOMESCO Finland

ERCP

3.5

25.5

124

365

SPAT1255

SPAT

Intravenous administration of medicine

2.2

25.5

262

1211

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

4.1

25.5

101

250

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.9

25.4

105

270

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

25.3

1746

13822

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

25.3

491

2890

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

25.2

324

1645

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.9

25.1

412

2295

Z94.4

ICD-10 Finland

Liver transplant status

16.1

24.9

TGC00

NOMESCO Finland

Bronchial lavation

4.1

24.7

238

JGB40

NOMESCO Finland

Excision of rectum and end ileostomy

130.6

24.6

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

24.6

1315

9923

N06AA09

ATC

amitriptyline; systemic

1.9

24.5

400

2221

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.9

24.4

153

539

127

Kela drug reimbursment

Transplant complication

4.8

24.2

174

J01FF01

ATC

clindamycin; systemic

1.5

24.2

1132

8319

N06AX16

ATC

venlafaxine; oral

1.6

24.2

640

4123

D07AB08

ATC

desonide; topical

1.8

24.1

447

2595

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

24.0

632

4063

E000002

ATC

1.7

24.0

496

2974

Z93

ICD-10 Finland

Artificial opening status

12.4

24.0

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.7

24.0

172

659

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

20.7

23.8

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

23.6

513

3125

B02.9

ICD-10 Finland

Zoster without complication

2.3

23.6

231

1043

J01MA01

ATC

ofloxacin; systemic

1.9

23.6

346

1850

M01CB01

ATC

sodium aurothiomalate; parenteral

13.9

23.5

R03AC12

ATC

salmeterol; inhalant

3.2

23.4

124

390

N06AB04

ATC

citalopram; systemic

1.5

23.3

920

6516

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.5

23.3

936

6654

WX892

NOMESCO Finland

Monitored bed care

2.0

23.3

297

1507

A03BA03

ATC

hyoscyamine; oral

5.8

23.2

115

R03BA08

ATC

ciclesonide; inhalant

2.0

23.1

302

1544

L88

ICD-10 Finland

Pyoderma gangrenosum

28.3

23.1

M54.5

ICD-10 Finland

Low back pain

1.4

23.1

1435

11107

XJW99

NOMESCO Finland

Other investigative procedure on digestive system

11.4

23.1

D99

ICPC

Disease digestive system other

5.1

23.1

148

WZC30

NOMESCO Finland

Teaching

1.7

23.1

514

3150

SPAT1263

SPAT

Sampling

1.4

23.0

1869

15148

UJF30

SPAT

8.8

23.0

4AC05

NOMESCO Finland

+∞

22.9

JHD00

NOMESCO Finland

Anal dilatation

6.1

22.9

105

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.8

22.9

405

2314

C07AA05

ATC

propranolol; systemic

1.5

22.9

856

5989

JHD33

NOMESCO Finland

Completing incision of fistula-in-ano

13.0

22.8

NH3EA

NOMESCO Finland

Feet X-ray examination with load

4.4

22.7

191

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

7.8

22.7

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

22.6

845

5908

JHD20

NOMESCO Finland

Incision of fistula-in-ano

5.2

22.6

139

M01AX17

ATC

nimesulide; oral

1.5

22.6

954

6851

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

17.6

22.6

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.8

22.4

151

559

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

22.4

536

3355

K30

ICD-10 Finland

Functional dyspepsia

1.7

22.3

452

2695

D07AA02

ATC

hydrocortisone; topical

1.6

22.3

579

3705

JFG50

NOMESCO Finland

Laparotomy with revision of enterostomy or colostomy

52.2

22.1

D29

ICPC

Digestive symptom/complaint other

3.4

22.0

108

321

XQ800

NOMESCO Finland

Prick test

1.9

22.0

318

1693

L04AB01

ATC

etanercept; parenteral

13.2

21.9

K52.80

ICD-10 Finland

(Hemorrhagic) colitis caused by antibiotics

13.2

21.9

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.2

21.6

237

1126

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.6

21.6

535

3380

J01FA15

ATC

telithromycin; oral

1.8

21.6

404

2349

WW500

NOMESCO Finland

Blood transfusion

2.5

21.5

167

669

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

21.3

1029

7583

R06AE09

ATC

levocetirizine; oral

1.6

21.2

609

3997

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

3.0

21.0

126

432

K29.7

ICD-10 Finland

Gastritis, unspecified

2.6

21.0

154

600

K56.0

ICD-10 Finland

Paralytic ileus

5.5

20.9

114

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

20.8

276

1421

N06AB10

ATC

escitalopram; oral

1.5

20.8

909

6561

R4190

NOMESCO Finland

Nutritional therapy

2.5

20.8

163

658

R06AX22

ATC

ebastine; oral

1.5

20.6

723

4978

XKD00

NOMESCO Finland

Uroflowmetry

1.6

20.5

538

3451

JJC00

NOMESCO Finland

Allogenic transplantation of liver

16.9

20.4

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

20.4

646

4344

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.7

20.4

141

528

R05

ICD-10 Finland

Cough

1.5

20.3

764

5342

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.0

20.3

278

1447

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.4

20.3

178

762

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

20.1

864

6210

JHW96

NOMESCO Finland

Other operation on anus or perianal tissue

8.4

20.1

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

5.3

20.0

116

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

4.9

19.9

134

R96

ICPC

Asthma

2.0

19.8

276

1446

M09.1*K50.9

ICD-10 Finland

Juvenile arthritis in Crohn's disease [regional enteritis]

+∞

19.8

D07XC01

ATC

betamethasone, combinations; topical

1.7

19.8

466

2902

R35

ICD-10 Finland

Polyuria

2.1

19.8

238

1180

A01AB04

ATC

amphotericin B; local oral

2.3

19.8

183

805

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.4

19.7

1171

8949

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

19.6

415

2503

R03AC03

ATC

terbutaline; inhalant

1.6

19.6

519

3334

5559X

ICD-9 Finland

Regional enteritis, Unspecified site

105.4

19.6

K73.0

ICD-10 Finland

Chronic persistent hepatitis, not elsewhere classified

200.7

19.6

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

5.7

19.6

R03AC13

ATC

formoterol; inhalant

2.6

19.5

148

588

K91.2

ICD-10 Finland

Postsurgical malabsorption, not elsewhere classified

19.4

19.5

N05BA01

ATC

diazepam; systemic, rectal

1.6

19.4

539

3506

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

10.6

19.3

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

19.3

1746

14280

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

19.3

2461

21156

-44

ICPC

Preventive immunization/medic

1.8

19.2

327

1842

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

19.1

774

5488

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.0

19.1

248

1266

R53

ICD-10 Finland

Malaise and fatigue

1.5

19.1

817

5863

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.4

18.8

1278

9983

AA1AD

NOMESCO Finland

CT of head and brain

1.4

18.6

876

6404

S01BA01

ATC

dexamethasone; ophthalmic (corticosteroids, plain)

2.4

18.6

155

646

JHD30

NOMESCO Finland

Incomplete incision of fistula-in-ano

10.3

18.6

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

18.5

3071

27292

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

7.6

18.5

G04CA02

ATC

tamsulosin; oral

1.5

18.5

695

4848

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.5

18.4

148

606

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.9

18.4

298

1650

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

4.0

18.4

188

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.1

18.3

101

329

JK3MN

NOMESCO Finland

Bile absorbtion isotope examination

30.1

18.3

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

5.3

18.2

104

XW000

NOMESCO Finland

Bone marrow biopsy

2.5

18.2

147

605

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

3.4

18.1

256

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

18.1

3373

30407

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.6

18.1

132

512

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

3.2

18.1

310

JF2AB

NOMESCO Finland

Colongraphy with X-ray

10.4

18.1

Z01.2

ICD-10 Finland

Dental examination

1.3

18.1

1863

15494

D02AE01

ATC

carbamide; topical

1.9

17.9

275

1494

A03FA02

ATC

cisapride; oral, rectal

1.8

17.9

298

1668

R42

ICD-10 Finland

Dizziness and giddiness

1.4

17.9

812

5892

R01AD01

ATC

beclometasone; nasal

1.5

17.9

610

4167

M05BA07

ATC

risedronic acid; oral

3.0

17.9

104

352

Z71.8

ICD-10 Finland

Other specified counselling

1.4

17.8

1022

7746

JX1XE

NOMESCO Finland

Other ultrasound examinaton of alimentary organs

18.1

17.7

JFA60

NOMESCO Finland

Stricturoplasty in small intestine

66.8

17.7

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

3.1

17.7

101

335

J01MA06

ATC

norfloxacin; oral

1.6

17.7

551

3685

R06AX13

ATC

loratadine; oral

1.5

17.6

651

4524

XG410

NOMESCO Finland

Flow-volume spirometry

2.5

17.6

139

563

H26.3

ICD-10 Finland

Drug-induced cataract

8.5

17.6

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.1

17.6

210

1036

ZXA10

NOMESCO Finland

Bilateral

1.5

17.6

678

4759

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

17.5

887

6568

D06

ICPC

Abdominal pain localized other

1.8

17.5

336

1969

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

5.1

17.5

109

Z93.3

ICD-10 Finland

Colostomy status

5.5

17.4

M01AH02

ATC

rofecoxib; oral

1.6

17.4

484

3146

B07.9

ICD-10 Finland

Verruca simplex

2.4

17.4

153

656

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

17.3

441

2803

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.8

17.3

115

423

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

4.1

17.1

166

A02BA04

ATC

nizatidine; systemic

1.8

17.0

287

1613

M79.7

ICD-10 Finland

Fibromyalgia

2.5

17.0

136

557

1380

FHL

Colonoscopy, left side

31.5

17.0

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.4

17.0

150

645

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

16.9

949

7153

S29

ICPC

Skin symptom/complaint other

1.5

16.9

660

4642

D02AX

ATC

Other emollients and protectives

2.4

16.9

141

591

JG1JB

NOMESCO Finland

Defekography with X-ray

5.4

16.9

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.9

16.8

244

1299

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

16.7

2671

23468

J31.0

ICD-10 Finland

Chronic rhinitis

1.8

16.7

309

1788

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

16.6

241

1285

JFB96

NOMESCO Finland

Other partial excision of intestine

90.3

16.6

WX004

NOMESCO Finland

Patient-controlled sedation

6.6

16.6

J46

ICD-10 Finland

Status asthmaticus

4.0

16.5

167

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

16.5

601

4160

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

16.5

295

1692

K02.1

ICD-10 Finland

Caries of dentine

1.3

16.5

2653

23319

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

16.5

409

2583

ZJX00

NOMESCO Finland

Double balloon technique in gastroenterological endoscopy

17.9

16.4

K52

ICD-10 Finland

Other noninfective gastroenteritis and colitis

17.9

16.4

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

3.1

16.3

295

K61.1

ICD-10 Finland

Rectal abscess

7.8

16.3

R03DA04

ATC

theophylline; systemic, rectal

2.6

16.2

121

478

S01BA04

ATC

prednisolone; ophthalmic (corticosteroids, plain)

3.0

16.2

324

G44.2

ICD-10 Finland

Tension-type headache

1.5

16.2

539

3658

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.3

16.1

143

619

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

12.8

16.1

A02BX02

ATC

sucralfate; oral

2.2

16.1

158

717

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

16.0

723

5231

JH1CM

NOMESCO Finland

Perianal extensive MRI with 3 Tesla magnet

24.5

16.0

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

10.1

15.9

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.9

15.9

223

1177

R19.4

ICD-10 Finland

Change in bowel habit

2.7

15.8

107

399

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

12.2

15.8

M05BX04

ATC

denosumab; parenteral

2.3

15.8

148

656

Y0599

ICD-8 Finland

Investigation of digestive system

3.3

15.8

247

H22.1*M45

ICD-10 Finland

Iridocyclitis in ankylosing spondylitis

60.2

15.7

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.6

15.7

400

2540

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.0

15.7

190

946

6403

FHL

Ileocal resection

33.4

15.7

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

15.7

1896

16023

A28

ICPC

Limited function/disability NOS

1.6

15.7

450

2947

R02

ICPC

Shortness of breath/dyspnoea

1.6

15.6

397

2518

4AA17

NOMESCO Finland

+∞

15.6

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

15.6

542

3711

WZA90

NOMESCO Finland

Other doctors statement

1.4

15.5

975

7481

56399

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Other

19.2

15.5

D07CC01

ATC

betamethasone and antibiotics; topical

1.5

15.5

509

3441

E87.6

ICD-10 Finland

Hypokalaemia

2.5

15.5

124

510

N05AH04

ATC

quetiapine; oral

1.4

15.5

703

5088

C01CA24

ATC

epinephrine; parenteral

1.9

15.5

235

1273

SPAT1131

SPAT

Colonoscopy

2.4

15.4

132

561

A06AD11

ATC

lactulose; oral

1.5

15.4

477

3183

J33.0

ICD-10 Finland

Polyp of nasal cavity

2.8

15.4

342

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

15.4

577

4017

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

15.3

501

3383

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.7

15.3

334

2031

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

5.0

15.3

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

15.2

1629

13532

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

15.2

990

7643

R10.0

ICD-10 Finland

Acute abdomen

2.4

15.2

128

541

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.3

15.1

144

645

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

4.8

15.0

102

A07AA11

ATC

rifaximin; oral

11.8

15.0

SPAT1254

SPAT

Administration of medicine

1.5

14.9

521

3570

SPAT1262

SPAT

Handing over of treatment supplies

1.4

14.9

661

4762

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.8

14.9

331

K55.9

ICD-10 Finland

Vascular disorder of intestine, unspecified

10.0

14.9

NF1AA

NOMESCO Finland

Hip X-ray examination

1.8

14.8

280

1634

B80

ICPC

Iron deficiency anaemia

2.8

14.7

334

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

14.7

1085

8538

0093A

ICD-9 Finland

Ill-defined intestinal infections, Diarrhoea of presumed infectious origin

3.4

14.6

213

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

5.0

14.5

M01AH05

ATC

etoricoxib; oral

1.3

14.5

2572

22724

R03AK08

ATC

formoterol and beclometasone; inhalant

2.5

14.4

113

459

N05BB01

ATC

hydroxyzine; systemic

1.8

14.4

242

1361

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.4

14.4

116

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

15.4

14.4

L43.9

ICD-10 Finland

Lichen planus, unspecified

2.9

14.4

299

N04BC05

ATC

pramipexole; oral

1.8

14.3

264

1528

K60.1

ICD-10 Finland

Chronic anal fissure

2.5

14.3

108

430

L43.8

ICD-10 Finland

Other lichen planus

3.0

14.2

277

E000006

ATC

1.7

14.2

269

1573

H05AA02

ATC

teriparatide; parenteral

9.7

14.2

A01

ICPC

Pain general/multiple sites

1.7

14.2

274

1612

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

14.1

445

2978

A99

ICPC

Disease/condition unspecnature/site

1.7

14.1

294

1765

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

14.1

118

498

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

14.0

1502

12450

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.0

14.0

191

996

N05CD07

ATC

temazepam; oral

1.6

14.0

421

2789

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

14.0

225

1248

5BA08

NOMESCO Finland

8.8

13.9

R01AD11

ATC

triamcinolone; nasal

1.6

13.9

348

2201

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

13.9

252

1451

R05FB02

ATC

cough suppressants and expectorants

1.3

13.9

1496

12406

SPAT1229

SPAT

Assessment of need for aid

1.8

13.9

255

1474

A03

ICPC

Fever

1.4

13.8

674

4944

JFA45

NOMESCO Finland

Endoscopic contact coagulation in colon

7.1

13.8

ZX108

NOMESCO Finland

Inhalation

6.2

13.8

J32.4

ICD-10 Finland

Chronic pansinusitis

4.5

13.7

108

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

13.7

516

3595

318

Kela drug reimbursment

Teriparatide

9.1

13.7

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.9

13.6

195

1037

NA6CG

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with high intensity magnet

6.4

13.6

R05

ICPC

Cough

1.4

13.6

862

6613

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

13.6

227

1272

M48.0

ICD-10 Finland

Spinal stenosis

1.6

13.6

371

2399

L52

ICD-10 Finland

Erythema nodosum

5.1

13.6

D07BC01

ATC

betamethasone and antiseptics; topical

1.5

13.6

450

3048

S97

ICPC

Chronic ulcer skin

2.0

13.6

164

816

J01AA04

ATC

lymecycline; systemic

1.5

13.5

560

3974

JGB61

NOMESCO Finland

Laparoscopic excision of rectum and ileoanal anastomosis

+∞

13.5

M79.1

ICD-10 Finland

Myalgia

1.5

13.5

504

3500

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.1

13.5

145

686

L04AA17

ATC

[U] adalimumab; parenteral

140.3

13.4

H00.1

ICD-10 Finland

Chalazion

2.1

13.4

150

724

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

2.1

13.4

148

711

J02AC02

ATC

itraconazole; systemic

1.4

13.4

722

5389

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

13.4

2320

20364

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.6

13.4

389

R15

ICD-10 Finland

Faecal incontinence

2.5

13.4

107

441

WX320

NOMESCO Finland

Spinalanesthesy

1.4

13.4

849

6513

N05BA12

ATC

alprazolam; oral

1.5

13.4

404

2679

K29.8

ICD-10 Finland

Duodenitis

4.4

13.4

111

L73.8

ICD-10 Finland

Other specified follicular disorders

4.1

13.4

125

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

18.2

13.3

K60.0

ICD-10 Finland

Acute anal fissure

3.9

13.3

140

L13

ICPC

Hip symptom/complaint

1.5

13.3

542

3835

SPAT1153

SPAT

Removal of sutures

1.3

13.2

1216

9859

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

13.2

1026

8124

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

13.1

426

2869

E000003

ATC

2.0

13.1

172

886

N06AB06

ATC

sertraline; oral

1.5

13.1

446

3041

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.1

13.0

149

726

K02.0

ICD-10 Finland

Caries limited to enamel

1.4

13.0

592

4281

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

13.0

592

4283

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.0

12.9

162

821

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

12.9

241

1402

N01

ICPC

Headache

1.5

12.9

416

2801

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.8

12.8

286

M01AC06

ATC

meloxicam; systemic, rectal

1.3

12.8

1440

11982

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.2

12.8

208

L28

ICPC

Limited function/disability (L)

1.5

12.8

502

3522

K65.0

ICD-10 Finland

Acute peritonitis

3.9

12.8

131

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.9

12.8

199

1090

JN4BD

NOMESCO Finland

Extensive body CT

1.6

12.7

368

2414

L03

ICPC

Low back symptom/complaint

1.3

12.7

946

7434

C10AC02

ATC

colestipol; oral

7.2

12.7

H20.1

ICD-10 Finland

Chronic iridocyclitis

4.1

12.7

117

N06AX12

ATC

bupropion; oral

1.7

12.7

270

1633

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.9

12.7

254

D95

ICPC

Anal fissure/perianal abscess

4.6

12.6

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.3

12.6

1226

10010

Z43.2

ICD-10 Finland

Attention to ileostomy

12.3

12.6

H01.0

ICD-10 Finland

Blepharitis

1.8

12.6

211

1187

C09CA06

ATC

candesartan; oral

1.4

12.5

807

6199

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

7.0

12.5

L95

ICPC

Osteoporosis

2.5

12.5

382

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.8

12.5

223

1277

E000007

ATC

1.8

12.5

214

1214

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

12.5

405

2730

JJ5AT

NOMESCO Finland

24.3

12.4

WX400

NOMESCO Finland

Inhalation anesthesy

1.9

12.4

179

955

K07

ICPC

Swollen ankles/oedema

2.2

12.4

130

610

M01AB55

ATC

diclofenac, combinations; oral

1.8

12.4

224

1292

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

12.4

262

1583

ZXA00

NOMESCO Finland

Right side

1.3

12.3

983

7799

N06AB03

ATC

fluoxetine; oral

1.5

12.3

510

3619

C03DA01

ATC

spironolactone; oral

1.6

12.3

317

2021

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.8

12.3

201

1121

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.9

12.3

260

G04CA01

ATC

alfuzosin; oral

1.6

12.3

355

2330

6402

FHL

Small bowel resection

14.3

12.2

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

12.2

424

2899

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

5.9

12.2

A04.9

ICD-10 Finland

Bacterial intestinal infection, unspecified

4.3

12.2

103

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

4.5

12.2

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.5

12.1

440

3037

6419

FHL

Other measure in this category

12.4

12.1

7200A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis

12.4

12.1

B03BA02

ATC

cyanocobalamin tannin complex; parenteral

5.8

12.0

JJA20

NOMESCO Finland

Open biopsy of liver

8.2

12.0

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

12.0

282

1755

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.9

12.0

167

881

J20

ICD-10 Finland

Acute bronchitis

1.6

12.0

338

2204

-50

ICPC

Medication/prescr/renewal

2.0

11.9

154

789

L01

ICPC

Neck symptom/complaint

1.4

11.9

529

3807

M04AA01

ATC

allopurinol; systemic

1.6

11.9

334

2177

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

3.5

11.8

156

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

11.8

339

2219

J37.0

ICD-10 Finland

Chronic laryngitis

2.2

11.8

114

519

L02

ICPC

Back symptom/complaint

1.6

11.8

348

2295

A04

ICPC

Weakness/tiredness general

1.5

11.8

479

3386

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

5.6

11.7

D06BB10

ATC

imiquimod; topical

1.9

11.7

181

992

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

9.6

11.7

K60.2

ICD-10 Finland

Anal fissure, unspecified

2.7

11.7

298

R01AD05

ATC

budesonide; nasal

1.6

11.7

290

1832

L20.0

ICD-10 Finland

Besnier prurigo

1.7

11.7

262

1610

K90.8

ICD-10 Finland

Other intestinal malabsorption

16.4

11.6

K90.4

ICD-10 Finland

Malabsorption due to intolerance, not elsewhere classified

16.4

11.6

JFA76

NOMESCO Finland

Closure of fistula of small intestine

30.1

11.6

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.3

11.6

109

487

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

11.6

233

1389

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

11.6

386

2615

SPAT1216

SPAT

Assessment of functional ability

1.4

11.6

492

3511

ZX100

NOMESCO Finland

Oral

3.4

11.5

159

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

11.5

230

1365

ZX114

NOMESCO Finland

Intramuscular

2.9

11.5

236

K07.60

ICD-10 Finland

Snapping jaw

1.8

11.5

194

1093

A04AA01

ATC

ondansetron; systemic, rectal

1.7

11.5

233

1391

D17

ICPC

Incontinence of bowel

4.1

11.5

105

WX306

NOMESCO Finland

Lumbar epidural anesthesy

1.6

11.4

273

1707

5563A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctosigmoiditis

120.3

11.4

B82

ICPC

Anaemia other/unspecified

2.5

11.4

333

N06AX26

ATC

vortioxetine; oral

1.7

11.4

234

1403

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

11.4

415

2870

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.3

11.4

102

447

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

11.4

2147

18911

A46

ICD-10 Finland

Erysipelas

1.5

11.3

440

3083

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

11.8

11.3

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

11.3

565

4157

D50.8

ICD-10 Finland

Other iron deficiency anaemias

3.0

11.2

207

B01AA03

ATC

warfarin; systemic

1.4

11.2

567

4183

UJF32

SPAT

2.7

11.1

289

K74.5

ICD-10 Finland

Biliary cirrhosis, unspecified

25.1

11.1

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.5

11.1

361

R60.0

ICD-10 Finland

Localized oedema

1.5

11.1

348

2328

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.0

11.1

218

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

11.1

492

3539

WX704

NOMESCO Finland

Intubation

1.6

11.1

264

1651

JAH01

NOMESCO Finland

Laparoscopy

1.8

11.0

181

1013

L17

ICPC

Foot/toe symptom/complaint

1.3

11.0

938

7502

XQ802

NOMESCO Finland

Epicutan test

1.9

11.0

161

865

J01DA08

ATC

[U] cefaclor; oral

1.4

11.0

469

3350

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.7

10.9

228

1372

K29.6

ICD-10 Finland

Other gastritis

3.4

10.9

156

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.3

10.9

102

458

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

4.4

10.9

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.1

10.9

117

559

R2110

NOMESCO Finland

Giving the first information

1.6

10.8

278

1772

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

10.8

1085

8868

GD1AD

NOMESCO Finland

Thorax CT examination

2.0

10.8

131

658

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

3.0

10.8

201

A09AA02

ATC

multienzymes (lipase, protease etc.)

2.5

10.8

318

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.8

10.8

173

959

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.4

10.8

511

3720

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.4

10.8

382

N06AX03

ATC

mianserin; oral

1.8

10.7

176

983

T78.4

ICD-10 Finland

Allergy, unspecified

1.8

10.7

165

905

L04AB05

ATC

certolizumab pegol; parenteral

21.5

10.7

A41.9

ICD-10 Finland

Sepsis, unspecified

2.2

10.6

110

515

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.8

10.6

185

1057

SDA02

NOMESCO Finland

Parodonthologic therapy

1.3

10.6

1386

11699

ULA02

NOMESCO Finland

Kolposcopy

1.5

10.6

391

2714

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.5

10.6

378

2605

K13.74

ICD-10 Finland

Lichen rubs planus in the mouth

3.0

10.5

199

SPAT1104

SPAT

Monitoring of emergency patient

1.7

10.5

224

1356

J45.8

ICD-10 Finland

Mixed asthma

2.6

10.5

293

B04AD01

ATC

10.0

10.5

JFH00

NOMESCO Finland

Total colectomy and ileorectal anastomosis

9.2

10.5

JGB96

NOMESCO Finland

Other proctectomy or excision of rectum

14.2

10.5

K62.4

ICD-10 Finland

Stenosis of anus and rectum

6.5

10.5

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.5

10.5

135

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.8

10.5

223

K59.9

ICD-10 Finland

Functional intestinal disorder, unspecified

2.9

10.4

217

5761C

ICD-9 Finland

Other disorders of biliary tract, Cholangitis[CHOLANGITIS SCLEROSIVA]

+∞

10.4

J33.8

ICD-10 Finland

Other polyp of sinus

2.9

10.4

218

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

10.4

484

3514

1470

FHL

Rectoscopy

4.4

10.4

C61

ICD-10 Finland

Malignant neoplasm of prostate

1.6

10.3

263

1672

J01EA01

ATC

trimethoprim; systemic

1.3

10.3

962

7783

K29.4

ICD-10 Finland

Chronic atrophic gastritis

2.6

10.3

272

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.8

10.3

162

895

N30.0

ICD-10 Finland

Acute cystitis

1.4

10.3

498

3636

L04AA11

ATC

[U] etanercept; parenteral

32.6

10.3

JFA96

NOMESCO Finland

Other local operation on intestine

32.6

10.3

M02AA10

ATC

ketoprofen; topical

1.4

10.3

574

4302

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.1

10.3

110

523

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

4.6

10.3

JFA56

NOMESCO Finland

Faecal microbiota transplantation

18.8

10.2

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

5.7

10.2

R31

ICD-10 Finland

Unspecified haematuria

1.5

10.2

299

1969

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.2

10.2

102

470

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.9

10.2

203

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

2.6

10.2

269

G43.9

ICD-10 Finland

Migraine, unspecified

1.7

10.1

222

1356

6451

FHL

Dilatation

4.3

10.1

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

3.0

10.1

196

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

6.2

10.1

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

10.1

131

674

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

7.9

10.1

Z01.9

ICD-10 Finland

Special examination, unspecified

1.7

10.1

199

1180

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.6

10.1

268

1727

N03AE01

ATC

clonazepam; systemic

1.7

10.0

209

1259

N89.5

ICD-10 Finland

Stricture and atresia of vagina

8.4

10.0

L02BB03

ATC

bicalutamide; oral

2.5

10.0

301

L08

ICPC

Shoulder symptom/complaint

1.3

10.0

679

5251

45599

ICD-8 Finland

Haemorrhoids

2.4

10.0

346

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

10.0

609

4633

RS221

NOMESCO Finland

2.8

9.9

213

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

3.2

9.9

157

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

5.3

9.9

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

9.9

191

1125

A04.8

ICD-10 Finland

Other specified bacterial intestinal infections

2.8

9.9

230

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.8

9.9

171

973

G04BD12

ATC

mirabegron; oral

1.5

9.9

319

2147

WX610

NOMESCO Finland

Patient controlled analgesia

4.1

9.9

RS224

NOMESCO Finland

6.7

9.9

K52.1

ICD-10 Finland

Toxic gastroenteritis and colitis

16.7

9.9

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.6

9.9

255

N01BB02

ATC

lidocaine; parenteral

3.2

9.8

153

A01AB10

ATC

natamycin; local oral

2.2

9.8

459

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

9.8

149

814

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

9.8

519

3855

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

10.6

9.8

D01AE16

ATC

amorolfine; topical

1.4

9.8

403

2858

M01AX01

ATC

nabumetone; oral

1.9

9.8

147

801

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.5

9.7

286

1885

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.4

9.7

345

D82

ICPC

Teeth/gum disease

1.2

9.7

1480

12683

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.9

9.7

135

715

XJH00

NOMESCO Finland

Transanal ultrasonography

1.7

9.7

182

1065

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

9.7

518

3854

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

9.7

2448

22074

DPA30

NOMESCO Finland

Sphenotomy

7.4

9.7

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

1.6

9.7

248

1583

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.5

9.7

277

KMAK

NOMESCO Finland

1.2

9.7

2370

21304

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.7

9.6

264

3824

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

9.6

676

5256

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

9.6

1675

14557

M01AB01

ATC

indometacin; systemic, rectal

1.6

9.6

223

1389

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

11.4

9.5

NG1DA

NOMESCO Finland

X-ray of knees

3.0

9.5

179

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

9.5

660

5118

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.5

9.5

372

2610

UDM02

NOMESCO Finland

Sinoscopy

2.5

9.5

280

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.6

9.5

224

1399

J01DA06

ATC

[U] cefuroxime; systemic

1.4

9.5

549

4137

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

9.1

9.5

5604

FHL

Vascular preparation or cannulation in the operating room

9.1

9.5

TAB00

NOMESCO Finland

Lumbar puncture

1.8

9.5

162

921

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.3

9.5

376

B02

ICD-10 Finland

Zoster [herpes zoster]

1.9

9.5

129

680

S01FA04

ATC

cyclopentolate; ophthalmic

3.3

9.5

136

L05

ICPC

Flank/axilla symptom/complaint

1.7

9.4

193

1159

291

Kela drug reimbursment

Tofacitinib

100.2

9.4

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

9.4

276

1820

B01AB10

ATC

tinzaparin; parenteral

1.6

9.4

234

1482

JF1CD

NOMESCO Finland

Extensive small bowel CT

17.5

9.4

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.0

9.4

117

593

WX290

NOMESCO Finland

Other blockade of nerve

1.2

9.4

1983

17555

E000004

ATC

2.4

9.4

343

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.7

9.4

203

1240

D01AC02

ATC

miconazole; topical

1.6

9.3

263

1718

ZX121

NOMESCO Finland

Central venous catheter

5.6

9.3

L50.3

ICD-10 Finland

Dermatographic urticaria

2.6

9.3

246

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.8

9.3

166

958

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.4

9.3

393

2802

-1

NOMESCO Finland

1.2

9.3

1436

12311

G01AA10

ATC

clindamycin; vaginal

1.3

9.3

602

4620

TQW40

NOMESCO Finland

Remowal of suture of skin

1.6

9.3

258

1681

R06.2

ICD-10 Finland

Wheezing

1.9

9.3

135

727

TJG20

NOMESCO Finland

Transanal irrigation

10.7

9.3

M35.7

ICD-10 Finland

Hypermobility syndrome

2.6

9.3

240

SPAT1260

SPAT

Consultation of another employee

1.3

9.3

643

4987

N06AB05

ATC

paroxetine; oral

1.6

9.3

239

1529

A29

ICPC

General symptom/complaint other

1.4

9.2

388

2760

C08CA05

ATC

nifedipine; systemic

1.7

9.2

193

1165

TEA00

NOMESCO Finland

Biopsy of lip

3.4

9.2

128

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.2

9.2

1561

13511

L50.8

ICD-10 Finland

Other urticaria

2.6

9.2

258

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.7

9.2

193

1169

JFK10

NOMESCO Finland

Freeing of adhesions in intestinal obstruction

6.0

9.2

R52.2

ICD-10 Finland

Other chronic pain

2.0

9.2

111

556

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.2

9.2

414

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.8

9.2

140

766

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.4

9.2

366

2581

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3003327) Ova and parasites identified in Stool by Light microscopy

731

1577

5.13

321.35

1.8

1.7

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2948

15596

2.73

313.69

5.8

2.9

30.7

34.7

u/l

2.28

2762

14827

(40758558) Short blood count panel - Blood

2349

11127

2.81

309.80

12.1

6.0

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

430

568

8.07

308.40

5.6

3.0

57.6

56.3

0.94

430

568

(3002179) Metamyelocytes/100 leukocytes in Blood

1025

2643

4.46

307.65

5.8

3.3

0.4

0.7

3.25

274

536

(3034770) Mitochondria Ab [Titer] in Serum

654

1121

6.42

307.65

1.5

1.2

951.1

839.7

titre

0.14

(3006504) Eosinophils/100 leukocytes in Blood

4544

20189

5.94

307.65

15.4

4.2

2.7

2.9

5.00

4399

18631

(3025941) Bacteria identified in Stool by Culture

1105

2598

4.98

307.65

1.5

1.2

—

(42870588) Differential panel, method unspecified - Blood

3952

13741

6.36

307.65

13.6

4.2

—

(3013115) Eosinophils [#/volume] in Blood

4909

22350

7.20

307.65

15.7

4.4

0.2

e9/l

7.68

4609

19336

(3001604) Monocytes [#/volume] in Blood

4853

21434

7.25

307.65

15.4

4.1

0.6

e9/l

0.10

4528

18173

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2994

10460

4.67

307.65

3.9

2.0

2.7

2.8

mg/l

1.16

2730

8846

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

556

842

7.17

307.65

1.7

1.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1241

3853

3.79

307.65

4.3

2.1

0.2

g/l

10.58

1176

3578

(3021440) Promyelocytes/100 leukocytes in Blood

1032

2793

4.25

307.65

6.4

3.5

0.1

0.2

1.13

321

685

(3024561) Albumin [Mass/volume] in Serum or Plasma

4762

18219

8.43

307.65

10.0

4.3

36.5

36.1

g/l

6.71

4608

16894

(3017143) Hepatitis C virus Ab [Presence] in Serum

1735

5617

3.92

307.65

1.5

1.6

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3999

23142

3.13

307.65

8.6

5.6

10.6

11.2

umol/l

2.99

3846

21882

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2104

2506

12.31

307.65

2.3

1.5

—

(3048689) Calprotectin [Mass/mass] in Stool

4532

5149

31.60

307.65

7.7

1.3

225.3

92.8

ug/g

71.63

4252

3883

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3802

21369

3.08

307.65

4.3

2.7

103.3

109.2

ug/l

0.67

3629

19921

(3018010) Neutrophils/100 leukocytes in Blood

4571

20799

5.82

307.65

14.9

4.2

57.5

56.4

10.16

4419

19314

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1625

5286

3.83

307.65

2.8

2.4

22.2

23.7

3.35

1422

4491

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

405

206.54

307.65

2.7

1.7

9.4

12.0

mg/l

0.98

350

(3017181) Myelocytes/100 leukocytes in Blood

1080

2923

4.28

307.65

6.2

3.4

0.7

0.9

2.17

339

745

(3028026) IgM [Mass/volume] in Serum or Plasma

952

2134

5.10

307.65

2.0

1.8

1.4

1.3

g/l

0.28

876

1935

(3022096) Basophils/100 leukocytes in Blood

4493

19467

6.00

307.65

15.5

4.3

0.7

12.28

4347

17995

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4416

18522

6.05

307.65

4.0

2.0

76.4

75.9

nmol/l

0.51

4247

16693

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

677

657

11.47

307.65

3.8

4.8

623.0

3054.6

iu/ml

0.43

(3005719) IgG [Mass/volume] in Serum or Plasma

1152

2756

4.92

307.65

4.6

2.2

11.4

10.6

g/l

7.19

1074

2489

(3007566) Smooth muscle Ab [Titer] in Serum

677

1127

6.63

307.65

1.6

1.2

171.1

115.5

titre

0.68

(3021589) Normoblasts [#/volume] in Blood

3585

20168

2.89

307.65

18.5

7.3

0.0

e9/l

0.12

3196

16234

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1305

680

24.16

307.65

1.7

1.5

0.7

2.6

iu/ml

0.65

340

138

(3019069) Monocytes/100 leukocytes in Blood

4557

20321

5.95

307.65

15.7

4.5

8.7

8.4

7.82

4419

18905

(3037522) Nuclear Ab [Titer] in Serum

1544

5375

3.51

307.65

1.6

1.3

675.8

512.7

titre

2.35

443

940

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1954

8163

3.05

307.65

1.6

1.7

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1753

6328

3.49

307.65

2.8

2.3

13.2

13.8

umol/l

2.25

1678

5827

(3002030) Lymphocytes/100 leukocytes in Blood

4595

21119

5.81

307.65

15.5

4.3

28.3

29.1

5.42

4444

19529

(3022145) Colonoscopy Study observation

3576

4312

18.70

307.65

2.1

1.2

—

(3013707) Erythrocyte sedimentation rate by Westergren method

5309

34329

5.30

307.65

7.7

2.8

12.7

10.7

mm/h

21.20

5066

31723

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1667

5799

3.58

307.65

2.7

2.3

2.4

g/l

1.34

1580

5339

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5701

35218

10.85

307.65

19.7

6.0

75.3

76.9

u/l

2.33

5586

33024

(3013650) Neutrophils [#/volume] in Blood by Automated count

5035

25521

6.65

307.65

17.6

7.6

4.0

e9/l

0.40

4714

21883

(3006315) Basophils [#/volume] in Blood

4859

21518

7.25

307.65

15.4

4.1

0.0

e9/l

2.10

4537

18228

(3019198) Lymphocytes [#/volume] in Blood

4897

22279

7.14

307.65

15.4

4.2

1.9

2.0

e9/l

6.03

4601

19346

(3025159) Blasts/100 leukocytes in Blood

982

2636

4.25

307.65

6.4

3.4

0.1

0.4

1.00

285

572

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3570

21301

2.64

289.55

7.3

5.9

1.2

mmol/l

1.39

3069

17939

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2680

13974

2.64

286.98

4.0

2.4

59.0

57.4

u/l

0.63

2512

12880

(3007164) IgA [Mass/volume] in Serum or Plasma

2031

9283

2.78

282.24

1.7

1.4

2.3

g/l

0.45

1370

5570

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3282

19213

2.54

270.67

6.5

5.3

1.2

mmol/l

2.90

3047

17290

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

533

1022

5.62

266.29

1.4

1.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

2062

9773

2.68

263.64

10.3

3.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

360

474

8.01

258.37

1.7

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

359

472

8.02

257.96

1.7

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

362

482

7.92

257.32

1.7

1.4

—

(40768797) Stomach Pathology biopsy report

1477

6026

2.92

250.54

1.3

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

351

467

7.92

249.58

1.7

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

350

468

7.87

247.79

1.7

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

350

469

7.86

247.33

1.7

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

458

817

5.98

246.76

1.2

286.8

240.1

u/ml

2.10

289

518

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3039

17830

2.41

239.95

2.4

1.9

94.2

97.2

pmol/l

2.98

1885

9133

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

468

877

5.70

239.22

1.2

—

(40768441) Liver Pathology biopsy report

265

275

10.03

229.22

1.8

1.4

—

(40768804) Tissue Pathology biopsy report

3194

19534

2.34

224.09

2.6

2.0

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

561

1321

4.58

219.43

1.5

1.2

7.4

4.4

u/ml

0.50

(3024980) IgG subclass 4 [Mass/volume] in Serum

335

494

7.12

217.10

1.9

1.3

0.7

g/l

0.17

266

367

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1038

3793

3.09

211.44

2.3

2.1

326.0

390.2

nmol/l

22.68

967

3468

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5905

49474

7.61

209.95

28.8

10.4

16.2

23.3

mg/l

87.71

5354

37510

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

249

278

9.30

203.79

1.4

1.1

271.9

177.1

titre

0.68

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

249

278

9.30

203.79

1.4

1.1

167.9

37.1

titre

—

(3023368) Bacteria identified in Blood by Culture

2031

10567

2.38

202.93

4.8

3.9

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

529

1266

4.48

202.32

1.4

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

531

1285

4.43

200.16

1.4

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

529

1277

4.44

200.04

1.4

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

583

1530

4.11

197.29

1.3

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

513

1223

4.49

197.05

1.5

1.4

283.8

281.6

ug/g

0.08

312

693

(3032080) INR in Blood by Coagulation assay

2799

16856

2.22

195.30

8.4

7.7

1.2

inr

3.87

842

4840

(3018418) pH of Serum or Plasma

2248

12378

2.29

195.25

4.5

3.7

7.4

0.38

375

2279

(3033658) Prothrombin time (PT) actual/Normal

2142

11664

2.29

189.98

6.5

3.5

95.6

92.0

9.95

2085

11369

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

414

862

5.08

187.36

1.7

1.2

4.7

8.6

iu/ml

0.60

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2061

11109

2.29

186.66

1.4

1.3

1.8

u/ml

1.30

485

3055

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1215

5148

2.70

186.17

4.9

2.5

7.0

7.7

umol/l

0.57

1059

4463

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

459

1057

4.62

183.93

1.8

1.4

527.2

198.6

titre

1.25

(46235355) HIV 1 and 2 tests - Meaningful Use set

1911

10147

2.29

177.81

1.8

1.9

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

332

605

5.75

174.10

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

543

1481

3.93

173.59

1.3

1.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1522

7428

2.40

171.36

2.1

1.7

1112.3

1155.3

nmol/l

0.90

1140

5658

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

336

639

5.51

168.20

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

317

595

5.57

160.91

1.5

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1029

4313

2.67

159.05

2.8

2.3

37.3

49.2

u/l

0.53

904

3697

(3037467) Urinalysis macro (dipstick) panel - Urine

4317

32232

2.17

158.01

5.3

3.6

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1773

9664

2.18

150.31

1.7

1.5

20.9

20.7

nmol/l

0.16

1584

8284

(3021879) Hepatitis B virus core Ab [Presence] in Serum

903

3640

2.74

150.19

1.3

1.5

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

238

395

6.23

137.20

1.4

1.1

55.8

58.2

u/l

0.23

157

264

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

142

126

11.52

136.56

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

135

114

12.09

134.03

21.5

24.5

126.6

118.6

ug/l

0.47

121

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

5475

46376

2.81

131.78

22.1

10.2

86.3

85.0

ml/min/173m2

4.01

4805

37631

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

199

288

7.11

130.76

1.3

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

198

290

7.02

128.67

1.3

1.2

—

(3017732) Neutrophils [#/volume] in Blood

744

2993

2.69

122.88

3.0

2.6

4.2

4.0

e9/l

1.08

538

2394

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

35.44

122.58

1.1

1.0

34.1

25.8

u/ml

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

35.44

122.58

1.1

1.0

27.2

17.3

u/ml

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

119

12.76

122.30

1.7

3390.4

33147.4

u/ml

0.49

(3013826) Glucose [Moles/volume] in Serum or Plasma

3627

26689

1.89

121.55

5.7

4.2

6.5

6.6

mmol/l

2.42

3441

24615

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

119

242.69

116.23

1.0

—

(3027945) Reticulocytes/100 erythrocytes in Blood

908

4164

2.39

113.16

3.8

2.3

1.9

1.7

2.33

832

3656

(3020564) Creatinine [Moles/volume] in Serum or Plasma

5901

52982

4.80

112.91

29.8

12.5

75.7

74.6

umol/l

2.29

5901

52959

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5919

53284

5.11

112.28

24.5

8.1

26.2

26.7

u/l

1.48

5849

51363

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

161

219

7.52

111.77

1.5

1.1

22.0

16.0

u/l

0.95

139

184

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

163

225

7.42

111.71

1.5

1.1

88.1

79.1

u/l

0.42

141

195

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

366

1025

3.74

111.68

1.2

1.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

4012

30928

1.87

111.21

5.4

3.9

1578.7

1851.8

e6/l

0.06

394

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

251

540

4.81

108.66

2.4

2.3

651.4

873.6

u/ml

0.13

(3023520) Reticulocytes [#/volume] in Blood

713

2998

2.56

106.93

3.1

2.4

71.5

69.3

e9/l

0.80

553

2217

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1180

6215

2.11

104.21

2.0

1.6

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

178

291

6.27

104.05

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

178

293

6.23

103.34

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

240

530

4.67

100.61

1.1

1.5

g/l

0.58

219

469

(3052851) Hemolysis interference index of Serum or Plasma

391

1228

3.33

99.89

3.2

2.9

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

5683

50416

2.93

99.79

22.2

12.8

3.9

4.0

mmol/l

43.70

5561

48948

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1030

5229

2.17

99.63

6.0

5.5

1.0

mmol/l

0.97

971

4878

(3019550) Sodium [Moles/volume] in Serum or Plasma

5669

50236

2.89

99.61

22.0

12.7

139.5

139.7

mmol/l

12.84

5556

48892

(3006922) Hepatitis E virus Ab [Presence] in Serum

182

318

5.87

99.42

1.1

—

(3042936) Bacteria identified in Isolate by Culture

1088

5694

2.11

97.04

2.2

1.9

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

322

912

3.67

96.46

1.3

1.4

21.2

15.9

u/ml

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

13.62

96.35

1.5

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

319

912

3.64

94.22

1.3

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

223

492

4.67

93.56

3.2

0.9

1.7

3.46

176

377

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1213

6711

2.01

92.51

4.4

3.1

0.8

mmol/l

5.66

1127

6253

(3004716) Salmonella sp identified in Stool by Organism specific culture

623

2626

2.53

92.37

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

122

153

8.12

90.75

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

122

153

8.12

90.75

1.4

—

(36304419) Bacteria [Presence] in Urine

1838

11717

1.81

90.45

3.7

2.7

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

299

841

3.69

90.44

1.3

1.4

97.3

115.2

u/ml

1.83

182

(3009261) Glucose [Presence] in Urine by Test strip

3109

23010

1.72

90.31

4.2

3.1

0.0

estimate

2.19

733

3900

(3030467) Casts [#/volume] in Urine by Automated count

1861

11923

1.81

89.98

3.7

2.8

0.3

0.4

e6/l

1.07

1458

8691

(3035350) Ketones [Presence] in Urine by Test strip

3071

22671

1.72

89.88

4.1

3.1

0.0

estimate

1.08

721

3909

(3021601) Nitrite [Presence] in Urine by Test strip

3068

22766

1.70

87.03

5.3

4.3

0.0

estimate

0.50

734

3998

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

138

213

6.61

85.29

1.4

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

170

322

5.40

85.15

3.1

3.9

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

140

220

6.49

85.05

1.4

1.3

—

(3002582) Erythrocytes [#/volume] in Urine

1977

13073

1.76

84.74

3.7

2.8

54.1

95.9

e6/l

1.19

1581

9730

(3014576) Chloride [Moles/volume] in Serum or Plasma

966

5097

2.06

83.19

8.1

6.6

104.7

104.6

mmol/l

0.19

958

4992

(3017354) Segmented neutrophils/100 leukocytes in Blood

162

301

5.50

82.87

3.1

3.4

58.7

56.7

0.45

110

195

(3032057) Clostridioides difficile [Presence] in Stool

11.65

81.78

1.9

—

(3018095) Leukocytes [#/volume] in Urine

2250

15549

1.71

81.56

4.3

3.2

69.6

93.1

e6/l

0.96

1675

10608

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1506

9288

1.83

81.14

2.2

1.6

34612921.5

34048722.3

pmol/l

0.01

1329

7786

(3019225) pH of Specimen

825

4138

2.15

81.08

4.5

3.7

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

844

4272

2.13

81.01

4.2

225.7

236.6

u/l

2.02

807

4022

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1267

7408

1.90

80.85

1.3

1.2

21.8

20.1

iu/ml

0.29

387

2142

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1737

11219

1.77

79.88

3.0

2.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1200

6931

1.91

79.32

1.3

1.2

9.9

5.2

u/ml

1.68

453

2823

(3044640) Blood type and Crossmatch panel - Blood

2156

14834

1.70

78.75

3.1

2.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

141

242

5.94

78.44

1.9

1.5

4.7

5.7

u/l

0.26

100

(3027135) IgG subclass 1 [Mass/volume] in Serum

154

292

5.38

77.04

1.4

1.2

7.7

6.7

g/l

1.56

104

196

(3024139) IgG subclass 3 [Mass/volume] in Serum

154

292

5.38

77.04

1.4

1.2

0.4

g/l

0.11

103

196

(3028192) IgG subclass 2 [Mass/volume] in Serum

154

293

5.37

76.75

1.4

1.2

3.2

3.1

g/l

0.36

104

200

(3015377) Calcium [Moles/volume] in Serum or Plasma

2147

14840

1.69

76.55

3.4

3.3

2.3

2.4

mmol/l

3.14

1876

13037

(4062490)

153

294

5.31

75.42

1.4

1.2

—

(3000850) Epithelial cells [#/volume] in Urine

1424

8817

1.80

74.84

2.8

2.3

5.7

6.4

e6/l

0.96

1295

7635

(3002385) Erythrocyte distribution width [Ratio]

4874

41828

1.83

74.79

30.9

13.5

13.8

13.5

23.80

4833

40895

(3041672) Baker's yeast Ab [Presence] in Serum

25.71

73.23

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

417

1622

2.69

72.36

1.9

1.6

1.4

1.5

g/l

0.97

377

1383

(3023420) DNA double strand Ab [Units/volume] in Serum

143

272

5.36

71.29

1.4

1.3

25.3

24.7

iu/ml

—

(36660697) Celiac disease serology panel - Serum

773

3967

2.09

70.96

1.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

300

995

3.12

69.71

1.6

1.4

0.2

g/l

1.57

280

944

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

307

1042

3.05

68.54

1.6

1.4

1.2

g/l

0.65

287

988

(3020779) Urea [Moles/volume] in Serum or Plasma

691

3448

2.13

68.16

8.0

6.8

8.8

9.0

mmol/l

0.38

651

3314

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

311

1095

2.94

65.04

1.7

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

788

4206

2.00

64.57

1.8

1.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2233

16120

1.61

64.09

3.9

3.0

40.2

47.3

ng/l

0.41

1464

9811

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1189

7269

1.79

63.94

3.1

2.5

1.1

e6/l

0.02

697

3890

(40761511) CBC panel - Blood by Automated count

5719

52574

2.47

62.79

21.5

10.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

445

1914

2.43

62.42

5.3

3.9

23.9

24.2

mmol/l

0.88

419

1736

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4109

34303

1.61

62.36

4.9

2.8

50.7

43.2

u/l

5.11

3880

32261

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

786

4241

1.98

62.31

1.9

1.6

—

(3000494) Fungus identified in Specimen by Culture

907

5150

1.89

61.72

1.6

1.3

—

(3000991) Gas panel - Venous blood

655

3331

2.08

61.14

8.5

7.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

872

4955

1.89

59.01

1.8

1.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1503

9996

1.67

58.97

1.8

1.7

1.2

1.1

mg/l

0.65

1160

7445

(3008898) HLA-B27 [Presence]

386

1601

2.51

58.51

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

366

1481

2.57

58.43

1.3

1.2

0.7

0.9

u/ml

0.14

135

(3026782) Osmolality of Urine

1298

8339

1.71

57.87

3.1

2.5

535.2

550.2

mosm/kgh2o

1.47

1148

7039

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2886

22554

1.53

55.97

4.9

3.8

—

(3002032) Base excess in Venous blood by calculation

679

3619

1.99

55.40

4.7

3.6

1.5

1.9

mmol/l

1.89

544

2949

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

231

753

3.15

55.21

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

496

2361

2.20

54.70

1.2

1.1

23.0

207.3

titre

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1106

6893

1.74

54.69

3.3

2.6

2.9

e6/l

0.03

617

3541

(3029937) Albumin [Presence] in Urine by Test strip

1706

11926

1.60

53.91

4.8

3.4

0.0

estimate

2.60

723

3862

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1056

6537

1.74

53.36

2.4

2.0

29.6

29.7

0.03

1011

6333

(3021447) Carbon dioxide [Partial pressure] in Venous blood

674

3635

1.96

53.03

4.8

3.6

5.8

kpa

0.05

638

3523

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1802

12847

1.57

51.96

2.3

2.0

238.2

228.4

u/l

0.08

1715

12054

(3026008) Bacteria identified in Urine by Culture

1824

13060

1.57

51.52

3.3

2.8

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

286

1092

2.70

51.26

3.5

3.1

1.4

mg/l

0.15

262

1010

(3007461) Platelets [#/volume] in Blood

5959

56499

3.68

50.99

39.2

16.2

269.3

253.1

e9/l

60.19

5911

55040

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

144

365

4.02

50.45

1.1

1.0

295.4

286.4

mg/l

0.60

128

328

(3035941) MCH [Entitic mass]

5960

56541

3.68

50.41

38.9

16.1

30.4

30.2

16.22

5931

55769

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

264

976

2.78

50.36

2.6

2.5

—

(3024731) MCV [Entitic volume]

5960

56546

3.67

50.30

39.0

16.1

91.7

90.5

69.29

5930

55775

(3010813) Leukocytes [#/volume] in Blood

5961

56567

3.68

50.17

39.2

16.2

6.8

6.6

e9/l

11.72

5904

54944

(3026361) Erythrocytes [#/volume] in Blood

5960

56555

3.66

50.10

39.2

16.1

4.4

4.5

e12/l

55.88

5903

54961

(3000963) Hemoglobin [Mass/volume] in Blood

5960

56572

3.65

49.73

39.3

16.2

133.9

136.4

g/l

39.02

5929

55794

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

105

210

5.07

49.51

1.1

1671.6

1526.7

miu/ml

0.52

105

210

(4035726)

692

3860

1.89

49.03

1.4

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

219

743

3.02

48.86

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

464

2250

2.15

48.69

2.2

2.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

140

6.07

48.18

3.4

2.7

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

341

1463

2.41

47.90

4.2

3.4

48.8

2385.1

u/ml

0.74

299

1258

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

473

2326

2.12

47.84

4.3

3.0

5.0

5.2

kpa

3.97

444

2159

(3009343) pH of Capillary blood

468

2296

2.12

47.62

4.2

3.0

7.4

0.26

281

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

218

753

2.97

47.12

1.4

1.2

5.3

1.9

u/ml

0.53

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

462

2268

2.12

46.92

1.7

1.5

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

453

2227

2.12

45.81

4.2

3.0

1.3

1.7

mmol/l

1.45

338

1635

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4072

34938

1.50

45.80

3.4

3.1

—

(40761536) Microorganisms panel - Urine sediment

678

3843

1.86

45.52

4.8

3.3

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

634

3521

1.89

45.36

6.6

1.3

mmol/l

0.21

611

3389

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

252

964

2.68

44.98

1.4

1.2

12.1

5.4

u/ml

1.11

131

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

250

954

2.69

44.84

1.4

1.2

13.9

2.8

u/ml

0.92

(3011397) Hemoglobin [Presence] in Urine by Test strip

1484

10406

1.56

44.81

4.1

3.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

271

1078

2.58

44.71

1.4

1.2

31.3

34.8

u/ml

0.10

(3022217) INR in Platelet poor plasma by Coagulation assay

841

5122

1.74

44.33

21.0

21.3

1.3

inr

0.02

119

754

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

177

5.20

44.30

1.5

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

553

2970

1.95

43.70

3.8

3.6

86.4

87.5

ng/l

0.11

487

2569

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2304

17809

1.47

43.39

4.4

3.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

535

2848

1.96

43.38

2.2

2.8

66.5

66.8

g/l

0.24

485

2595

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

157

469

3.41

43.27

1.5

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

128

6.00

43.15

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

160

5.37

42.92

1.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1494

10603

1.54

42.35

3.0

2.7

1201.9

1252.6

ng/l

0.16

1259

8850

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

723

4270

1.79

42.26

3.7

4.1

30.8

ug/l

2.32

550

3357

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

210

756

2.84

42.10

1.7

1.4

—

(40768443) Skin Pathology biopsy report

378

1803

2.17

41.24

1.2

—

(3022313) Gas panel - Capillary blood

354

1661

2.20

40.23

4.6

3.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

341

1583

2.22

39.78

2.1

1.5

40.0

39.8

u/l

0.09

302

1401

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

161

520

3.15

39.11

1.8

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

204

754

2.76

38.93

1.7

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

235

933

2.58

38.92

2.2

1.6

11.4

11.1

mg/l

0.25

214

868

(3009542) Hematocrit [Volume Fraction] of Blood

5160

47143

1.62

38.90

26.7

12.0

39.8

40.1

2.88

3872

36064

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

296

1307

2.33

38.89

2.0

1.9

7.2

2.4

ug/l

0.48

266

1158

(3026493) Urate [Moles/volume] in Serum or Plasma

1526

11062

1.51

38.57

2.8

2.2

2678.3

4857.4

umol/l

2.05

1354

9640

(3005322) IgE [Units/volume] in Serum or Plasma

485

2597

1.94

38.53

1.4

1.2

190.4

174.4

u/ml

0.17

449

2376

(3009871) Measles virus Ab [Titer] in Serum

126

5.69

38.21

1.6

1.7

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

313

1428

2.26

38.07

1.1

3.2

5.6

u/ml

0.70

206

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

203

758

2.74

37.99

1.6

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

345

1649

2.16

37.40

2.2

1.8

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

131

384

3.46

37.21

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

321

1495

2.21

37.13

4.7

3.1

24.5

24.8

mmol/l

1.20

303

1387

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4356

38534

1.46

36.75

4.2

3.9

14.8

14.6

pmol/l

8.20

4025

35320

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

109

287

3.85

36.29

1.1

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

124

360

3.50

35.76

2.0

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1692

12702

1.46

35.31

3.6

2.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

319

1516

2.17

35.07

2.1

1.7

—

(3011412) CD3 cells [#/volume] in Blood

114

326

3.54

33.66

2.1

2.6

1.1

1.2

e9/l

0.59

195

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

6.09

33.55

1.8

1.4

9.8

8.8

ug/l

0.79

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

242

3.97

33.15

2.1

2.6

451.8

545.4

e6/l

1.10

210

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

196

4.33

32.93

1.2

1.1

23.7

24.7

u/l

0.05

144

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

197

4.31

32.72

1.2

1.1

86.4

83.8

u/l

0.09

150

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4999

45768

1.52

32.70

5.1

4.6

1.7

2.0

mu/l

3.90

4667

42319

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

234

3.98

32.17

2.1

2.7

0.1

0.2

e9/l

6.40

208

(3021788) Differential panel - Synovial fluid

142

480

3.01

31.95

1.6

1.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

516

3010

1.78

31.07

3.9

3.0

4.6

4.7

kpa

0.10

481

2910

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

424

2348

1.87

30.25

1.6

1.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

692

4412

1.64

30.01

7.5

7.1

5.0

5.1

kpa

2.78

664

4214

(3027801) Oxygen [Partial pressure] in Arterial blood

692

4412

1.64

30.01

7.4

7.1

12.9

13.0

kpa

0.26

663

4212

(3039162) Centromere protein B Ab [Units/volume] in Serum

135

460

2.98

29.97

1.4

1.2

51.8

52.0

u/ml

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

251

3.75

29.94

3.9

2.2

93.4

97.7

0.52

231

(40761535) Cells panel - Urine sediment

552

3327

1.72

29.60

3.7

2.9

—

(3003396) Base excess in Arterial blood by calculation

691

4420

1.64

29.55

7.4

7.1

0.5

0.9

mmol/l

1.48

529

3410

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

154

570

2.75

29.36

1.5

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

199

835

2.43

29.34

1.4

1.2

38.5

38.7

u/ml

0.01

(3004616) Nuclear Ab [Presence] in Serum

126

421

3.04

28.96

1.3

1.2

—

(3051651) Icteric interference index of Serum or Plasma

230

3.82

28.86

3.3

3.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

166

645

2.62

28.77

1.8

1.5

10505.0

13402.1

e6/l

0.40

123

438

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

269

1300

2.12

28.32

2.2

408.8

720.4

ug/l

0.84

246

1221

(3016502) Oxygen saturation in Arterial blood

622

3919

1.65

28.18

7.9

7.6

96.2

96.1

0.12

599

3761

(3037756) Immunofixation for Serum or Plasma

159

617

2.62

27.65

1.9

1.8

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1075

7697

1.48

27.60

3.3

2.9

2.4

mmol/l

0.43

927

6712

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

268

1307

2.10

27.55

3.0

2.4

3.4

3.6

g/l

1.77

254

1246

(3026389) Candida sp identified in Specimen by Organism specific culture

166

660

2.56

27.47

1.5

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

170

684

2.53

27.44

1.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

218

989

2.25

26.89

3.0

3.8

2.1

2.4

ratio

0.14

(3034860) Kappa light chains.free [Mass/volume] in Serum

223

1025

2.22

26.65

3.0

3.9

49.3

56.3

mg/l

0.36

179

847

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

263

3.50

26.51

2.1

2.8

577.3

748.0

e6/l

1.54

107

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

172

708

2.47

26.47

1.5

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

563

3513

1.66

26.43

3.4

2.4

69.2

70.7

ml/min/173m2

0.38

237

1324

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

222

1023

2.21

26.37

3.0

3.9

31.4

51.8

mg/l

1.82

177

842

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

268

1332

2.06

26.19

2.6

2.3

187.8

181.9

0.55

255

1266

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

107

345

3.14

26.17

1.7

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

106

343

3.13

25.78

1.8

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

6.27

25.67

1.7

1.3

—

(3003181) Sodium [Moles/volume] in Urine

160

646

2.52

25.66

1.7

1.3

66.8

64.1

mmol/l

0.26

112

523

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1131

8282

1.45

25.65

3.7

3.2

486.6

573.5

ng/l

0.17

776

5970

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

123

435

2.87

25.59

8.0

6.1

11.5

11.2

mg/l

0.22

118

407

(3013512) EKG study

1597

12475

1.38

24.92

3.8

3.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

119

428

2.82

24.02

1.6

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

263

3.34

23.68

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

263

3.34

23.68

1.3

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

211

997

2.16

23.56

1.3

1.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

576

3718

1.61

23.52

8.3

7.8

119.7

122.1

g/l

1.98

561

3572

(21494815) CD4 cells/100 lymphocytes in Specimen

310

3.13

23.46

1.9

2.5

45.7

40.7

0.53

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

275

1436

1.96

23.41

2.3

2.1

94.7

92.7

0.61

265

1332

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

115

412

2.83

23.39

1.5

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

266

3.30

23.26

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

266

3.30

23.26

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

266

3.30

23.26

1.3

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

5.32

23.20

1.2

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

292

3.18

23.14

1.7

1.3

48.1

59.6

1.54

168

(3036489) Thrombin time

312

1707

1.87

23.07

2.2

1.9

21.3

0.01

280

1473

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

263

3.30

22.99

1.3

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

112

401

2.83

22.82

3.4

3.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

170

745

2.32

22.79

3.1

4.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

227

1119

2.07

22.70

2.3

2.5

0.7

0.8

g/l

0.31

192

968

(3019060) Gas panel - Arterial blood

400

2370

1.74

22.68

4.7

5.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

244

1236

2.01

22.65

2.0

2.5

3.1

3.0

g/l

1.15

190

960

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

641

4278

1.56

22.65

3.7

3.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

179

807

2.26

22.46

3.5

155.7

770.3

u/ml

1.12

164

736

(3023183) Ammonium ion [Moles/volume] in Plasma

186

853

2.22

22.39

3.4

2.8

30.6

36.5

umol/l

2.59

169

722

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

128

498

2.60

22.21

1.5

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

112

412

2.75

21.70

1.8

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

7.53

21.20

1.3

1.0

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

251

1315

1.95

21.18

2.0

2.5

3.8

g/l

0.14

185

932

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

251

1317

1.94

21.08

2.0

2.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

251

1318

1.94

21.04

2.0

2.5

7.3

7.2

g/l

0.15

196

984

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

111

4.53

20.97

2.6

3.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

311

2.99

20.83

1.8

1.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1322

10269

1.37

20.74

1.7

1.5

—

(3042631) Mycobacterium sp identified in Specimen

104

379

2.77

20.54

3.2

2.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

236

1227

1.96

20.37

2.0

2.5

10.8

10.1

g/l

1.18

197

1031

(3028433) Virus identified in Specimen by Culture

110

4.48

20.28

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

442

2785

1.63

19.84

1.0

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

161

734

2.23

19.70

2.3

2.2

11.2

6.0

umol/l

1.31

128

537

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

199

990

2.04

19.46

2.1

2.4

0.0

g/l

0.01

184

908

(3042733) HLA Ab [Presence] in Serum

114

4.33

19.40

3.2

5.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

110

4.39

19.37

1.1

1.0

—

(3023419) Bacteria identified in Sputum by Culture

317

2.87

18.96

3.5

1.9

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

4.91

18.94

1.9

1.6

0.3

0.4

ug/l

0.63

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

204

1035

2.00

18.90

2.0

2.3

37.4

38.4

g/l

1.24

173

890

(3019150) Specific gravity of Urine by Refractometry

1269

9973

1.34

18.12

4.6

3.4

1.0

kg/l

0.25

180

1522

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

235

3.13

18.02

1.9

2.1

—

(3045414) Leukocytes [Presence] in Urine

333

2004

1.70

17.84

2.1

1.8

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

184

921

2.03

17.72

2.1

2.4

0.0

g/l

0.00

170

846

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

264

2.98

17.68

1.2

22.3

28.8

u/ml

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

5.25

17.46

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

5.25

17.46

1.1

1.2

103.9

96.0

1.04

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

236

1295

1.86

17.34

1.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

181

908

2.02

17.33

2.1

2.4

0.0

g/l

0.00

168

845

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

197

3.27

17.02

1.6

1.1

5.8

u/l

0.01

168

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

158

761

2.10

16.89

1.1

1.4

3.7

u/ml

3.60

397

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

115

4.02

16.61

1.6

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

115

4.02

16.61

1.6

2.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

220

1205

1.86

16.27

3.2

3.1

0.3

u/ml

0.35

114

679

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

117

3.95

16.24

1.6

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

149

3.58

16.23

1.7

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

149

3.58

16.23

1.7

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

149

3.58

16.23

1.7

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

149

3.58

16.23

1.7

1.9

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

245

2.96

16.20

1.8

1.3

—

(3028626) Oxygen [Partial pressure] in Capillary blood

162

801

2.05

16.17

4.2

2.7

8.5

8.4

kpa

0.04

150

750

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

349

2182

1.64

16.15

10.2

9.4

—

(1175426) CD3 cells/100 lymphocytes in Blood

267

2.87

16.15

1.7

2.1

75.8

72.0

1.23

260

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

158

776

2.06

16.06

1.4

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

158

776

2.06

16.06

1.4

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

12.34

16.02

1.8

1.7

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

263

2.87

15.99

1.7

2.1

10.1

15.2

2.92

124

(3000060) B lymphocytes [#/volume] in Blood

4.32

15.89

1.5

1.9

170.8

161.5

e6/l

0.07

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

327

2023

1.65

15.78

9.9

9.1

23.9

24.2

mmol/l

0.96

308

1897

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

383

2467

1.59

15.68

9.2

8.7

0.7

0.27

375

2451

(3002256) Pathology report gross observation

833

6261

1.38

15.60

1.3

1.2

—

(3014271) Vancomycin [Susceptibility]

168

3.36

15.55

2.8

2.6

—

(3000492) Spirometry study

616

4398

1.45

15.46

1.5

1.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

375

2419

1.59

15.26

6.4

6.8

24.1

24.4

mmol/l

0.88

351

2239

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

217

1209

1.82

15.22

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

199

1084

1.86

15.00

1.7

1.6

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

117

525

2.25

14.98

2.8

3.3

9.6

14.9

nmol/l

0.20

110

510

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

240

2.90

14.96

1.5

1.3

26.0

0.00

147

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

168

3.29

14.86

1.8

1.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

169

875

1.96

14.85

3.0

2.8

24.3

24.7

mmol/l

0.75

147

770

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

210

3.02

14.73

1.9

1.3

28.7

16.6

u/ml

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

165

3.29

14.58

1.8

1.3

—

(4015189)

5.40

14.45

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

257

2.78

14.32

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

257

2.78

14.32

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

257

2.78

14.32

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

173

3.20

14.19

1.3

1.1

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

377

2477

1.56

14.17

9.4

8.6

1.3

0.57

368

2464

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

139

683

2.06

14.16

1.5

1.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

485

3363

1.48

14.14

3.9

3.4

1.2

mmol/l

0.08

441

2893

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

121

564

2.17

14.14

2.6

—

(4010399)

417

2804

1.52

14.10

1.4

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

212

1202

1.79

14.06

1.2

1.1

—

(1616796) Gas panel - Central venous blood

162

843

1.95

14.05

3.9

3.2

—

(3012501) Base excess in Blood by calculation

164

858

1.94

14.00

4.4

3.4

2.6

2.4

mmol/l

0.60

117

547

(3024471) HLA-A [Type]

126

3.59

13.91

1.0

—

(3006245) CD3-CD19+ cells/100 cells in Blood

136

3.48

13.83

1.6

1.9

11.8

9.6

0.52

128

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

476

3309

1.48

13.69

2.4

2.2

5.7

7.2

ug/l

1.18

404

2914

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

198

3.00

13.66

1.7

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

242

2.79

13.59

1.4

1.2

359290.2

164196.7

e6/l

0.53

168

(3013293) Extractable nuclear Ab [Presence] in Serum

5.87

13.51

1.4

1.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

113

526

2.17

13.27

1.3

—

(44790048)

369

2.41

13.21

1.7

1.2

—

(44790049)

369

2.41

13.21

1.7

1.2

—

(44806118)

369

2.41

13.21

1.7

1.2

—

(44790047)

369

2.41

13.21

1.7

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

4.30

13.09

1.3

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

760

5781

1.36

13.08

1.5

1.4

—

(3024932) HLA-DR beta [Type]

123

3.51

12.90

1.2

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

313

2.51

12.87

1.1

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

158

841

1.90

12.85

2.4

2.1

126.2

131.0

g/l

1.50

106

620

(3010421) pH of Blood

182

1016

1.82

12.74

4.2

3.6

7.4

0.45

160

844

(3044889) 12 lead EKG panel

3615

33155

1.22

12.69

3.7

3.3

—

(3044927) Protein electrophoresis panel - Urine

299

2.53

12.56

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

293

1872

1.59

12.45

1.7

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

6.47

12.36

1.4

1.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

278

2.57

12.34

3.8

3.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

210

2.83

12.33

1.2

0.2

0.9

u/ml

0.50

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

126

636

2.00

11.99

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

102

476

2.16

11.95

2.7

2.0

40.9

22.7

mg/l

1.31

126

(3049717) Cytology report of Urine Cyto stain

234

1431

1.66

11.87

2.5

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

724

5553

1.34

11.75

4.2

33.5

31.9

3.21

542

3800

(3045424) Erythrocytes [Presence] in Urine

135

708

1.93

11.52

1.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

452

3216

1.44

11.51

2.4

2.3

22.0

23.4

au/ml

0.08

226

(3035637) Corticotropin [Mass/volume] in Plasma

108

528

2.06

11.24

1.6

—

(3029075) Extractable nuclear Ab panel - Serum

111

3.44

11.08

1.2

1.1

—

(3016038) Potassium [Moles/volume] in Urine

241

2.59

10.98

1.8

1.1

34.6

36.0

mmol/l

0.11

210

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

247

2.57

10.97

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

123

637

1.95

10.91

1.2

—

(3037121) Protein [Mass/volume] in Urine

225

1393

1.64

10.91

3.4

3.0

0.3

0.4

g/l

0.69

104

578

(40767503) Oxygen content in Capillary blood by calculation

144

786

1.85

10.90

2.7

2.3

16.0

16.7

1.10

385

(3028679) Herpes simplex virus Ab [Presence] in Serum

260

2.52

10.86

1.1

1.2

—

(3047181) Lactate [Moles/volume] in Blood

212

1296

1.66

10.81

6.3

5.8

1.3

1.2

mmol/l

0.43

193

1131

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

134

719

1.88

10.70

1.3

1.2

2.6

3.0

u/ml

0.23

224

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

134

720

1.88

10.66

1.1

3.4

12.0

au/ml

—

(21494890) Protein electrophoresis panel - 24 hour Urine

351

2.27

10.48

1.8

2.3

—

(21494434) Karyotype in Bone marrow

314

2.34

10.44

1.2

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

321

2.32

10.38

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

158

2.93

10.31

1.8

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

158

2.93

10.31

1.8

1.5

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

232

2.56

10.24

1.2

1.6

—

1437007.6

iu/ml

—

(3044941) Cell count panel - Synovial fluid

467

2.07

10.17

1.5

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.52

10.02

2.3

2.8

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

172

2.80

9.98

1.1

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

129

700

1.86

9.98

1.3

1.2

3.5

3.8

u/ml

0.23

300

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

409

2935

1.42

9.95

1.3

60.0

49.5

au/ml

0.26

133

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

4.52

9.76

2.1

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

483

2.02

9.67

1.3

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

198

2.64

9.64

1.3

60.0

67.5

titre

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

4.30

9.57

1.1

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

165

2.80

9.56

1.1

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

347

2.21

9.49

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

129

3.04

9.36

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

320

2222

1.46

9.30

2.3

—

(3030313) Adrenal Ab [Titer] in Serum

4.89

9.30

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

829

6683

1.28

9.25

1.7

1.8

1.4

0.35

722

5962

(3042111) Morphology [Interpretation] in Bone marrow Narrative

115

618

1.88

9.20

2.6

1.5

—

(3024928) Oxygen saturation in Venous blood

151

889

1.72

8.93

3.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

125

698

1.81

8.87

1.2

—

(3022621) pH of Urine by Test strip

406

2981

1.39

8.67

3.4

2.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

426

3165

1.37

8.47

3.0

2.5

154.2

167.9

ng/l

0.32

379

2864

(3022493) Free Hemoglobin [Mass/volume] in Plasma

166

2.66

8.36

1.4

5.3

60.7

64.1

mg/l

0.20

109

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

264

1806

1.48

8.31

3.1

2.6

0.7

0.6

0.18

255

1726

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

422

3142

1.37

8.28

3.2

3.4

4.4

4.5

pmol/l

1.84

365

2801

(3008536) Aspergillus sp Ab [Presence] in Serum

4.21

8.18

4.9

2.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

115

643

1.80

8.16

1.3

0.2

0.4

nmol/l

0.81

(3045142) Bone marrow Pathology biopsy report

417

2.00

8.14

1.4

1.3

—

(3021901) Oxygen saturation in Capillary blood

112

622

1.82

8.13

3.2

2.5

—

(3011985) Renin [Units/volume] in Plasma

108

594

1.83

8.09

1.7

1.5

55.4

55.5

mu/l

0.00

525

(3014051) Protein [Presence] in Urine by Test strip

165

1024

1.63

8.03

2.6

2.1

—

(3018405) Lactate [Moles/volume] in Arterial blood

205

1340

1.55

8.01

3.4

3.8

1.4

mmol/l

0.09

197

1323

(3004119) Hemoglobin [Mass/volume] in Venous blood

337

2432

1.41

7.98

3.6

3.1

129.8

131.0

g/l

0.45

320

2371

(3019420) Tryptase [Mass/volume] in Serum or Plasma

218

2.40

7.97

2.0

1.5

9.5

8.0

ug/l

0.20

188

(3003338) MCHC [Mass/volume]

4625

44171

1.20

7.93

32.6

14.0

331.8

333.0

g/l

17.40

4611

43856

(3027570) Oxalate [Moles/time] in 24 hour Urine

5.84

7.85

1.0

1.6

380.4

344.7

umol/24h

0.20

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

221

2.36

7.74

1.6

2.5

37.3

41.0

0.40

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

167

2.59

7.74

2.3

2.5

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

209

2.40

7.72

1.6

1.4

12.4

12.7

u/l

0.10

204

(40768446) Kidney Pathology biopsy report

150

2.68

7.71

1.5

1.6

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

412

1.98

7.70

1.9

1.6

—

(3020891) Body temperature

227

1531

1.50

7.68

4.4

4.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

183

1178

1.57

7.67

1.3

502.5

504.2

mg/l

0.02

175

1121

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

112

2.96

7.64

4.5

3.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

229

2.33

7.61

1.3

1.2

—

(4268621)

491

1.89

7.60

2.5

2.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

128

756

1.71

7.55

2.7

2.8

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

445

1.92

7.44

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

459

3520

1.33

7.43

2.3

2.1

12.7

12.8

nmol/l

0.03

410

3124

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

3.16

7.24

1.2

1.1

71.8

90.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1074

9140

1.21

7.22

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

241

2.25

7.21

1.1

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

102

573

1.79

7.18

1.3

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

3.09

6.99

1.2

1.1

51.0

85.3

—

(3048879) Bone marrow aspiration report

3.05

6.87

2.2

2.0

—

(3039000) Anion gap in Blood

146

917

1.61

6.83

7.5

7.0

11.6

11.2

mmol/l

0.81

138

814

(3018572) Chloride [Moles/volume] in Blood

146

918

1.60

6.80

7.5

7.0

105.2

105.3

mmol/l

0.11

138

815

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

239

2.19

6.51

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

107

2.81

6.40

1.2

1.1

390.3

276.3

pmol/l

0.50

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

159

1036

1.55

6.38

1.3

1.2

3.6

3.7

mmol/l

0.27

148

974

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

535

1.77

6.38

1.1

95.7

97.4

0.24

505

(3008295) Osmolality of Serum or Plasma

430

1.85

6.21

1.4

1.5

274.7

281.8

mosm/kgh2o

2.16

342

(3017704) Immunofixation for Urine

174

2.37

6.19

1.8

1.7

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

3.66

6.19

1.1

1.7

8.2

879076.3

nmol/l

1.08

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

669

5508

1.24

6.17

8.3

5.8

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

226

2.18

6.11

2.3

1.6

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

110

2.74

6.10

1.4

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

110

2.74

6.10

1.2

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

560

1.73

6.01

1.3

—

nmol/l

—

(3025130) Human papilloma virus identified in Specimen

123

767

1.62

5.98

2.0

1.7

—

(3043409) Potassium [Moles/volume] in Arterial blood

170

1142

1.50

5.96

3.5

4.1

3.8

3.9

mmol/l

2.37

158

1072

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

129

2.57

5.94

1.3

1.2

111.0

109.8

0.12

117

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

304

1.98

5.86

1.3

1.2

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

180

2.29

5.76

1.0

1.1

309.2

173.1

iu/ml

0.72

180

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

108

2.69

5.74

1.2

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

227

1625

1.41

5.73

6.1

5.2

1.0

0.9

1.58

217

1516

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

257

1881

1.38

5.69

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

252

1840

1.39

5.67

3.5

3.1

24.7

25.3

mmol/l

1.81

240

1777

(3044290) Cell count panel - Cerebral spinal fluid

148

977

1.53

5.65

1.6

1.3

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

109

2.67

5.65

1.2

1.3

116.2

130.2

nmol/l

0.16

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.06

5.62

2.2

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

278

3690

0.74

5.55

1.3

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.82

5.53

1.2

1.0

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

116

728

1.60

5.53

1.1

124.8

116.7

1.87

111

658

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

243

2.07

5.49

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

178

2.26

5.47

1.2

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

141

2.42

5.44

1.4

1.2

0.3

g/l

2.69

108

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

355

1.87

5.44

3.1

2.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

136

890

1.54

5.42

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4919

47633

1.17

5.42

4.4

4.1

5.8

5.9

mmol/l

3.91

4543

43809

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

227

1642

1.40

5.41

6.1

5.1

1.6

1.7

0.32

217

1528

(3002523) Influenza virus A Ag [Presence] in Specimen

136

891

1.54

5.39

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

328

1.90

5.38

1.1

1.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4632

44663

1.16

5.34

5.5

5.1

38.5

39.1

mmol/mol

4.82

4333

41617

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

206

2.14

5.33

1.1

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

486

1.72

5.18

1.1

—

(4306422)

117

749

1.57

5.16

1.2

—

(4024509)

428

1.76

5.13

1.9

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

844

7242

1.19

5.11

2.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

158

2.29

5.10

1.2

1.0

71.7

91.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

766

6523

1.20

5.05

2.0

—

(3024263) Appearance of Synovial fluid

159

2.27

5.03

2.2

1.3

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

154

2.28

4.94

1.2

1.1

74.9

92.9

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

9.01

4.78

1.1

—

(3003129) Base excess in Capillary blood by calculation

2.74

4.76

1.7

1.6

0.7

0.8

mmol/l

0.04

(21494814) CD8 cells/100 lymphocytes in Specimen

139

2.31

4.67

1.7

2.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

273

1.91

4.66

1.1

8.0

10.1

iu/ml

0.16

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.14

4.62

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

115

2.44

4.62

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

115

2.44

4.62

1.2

1.1

—

(3006270) Folate [Moles/volume] in Blood

390

1.75

4.61

1.1

357.1

380.3

nmol/l

0.40

351

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.49

4.61

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

332

1.82

4.58

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

275

1.90

4.57

1.1

1.0

11.2

nmol/l

0.75

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

117

774

1.52

4.51

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

161

2.18

4.48

1.2

1.1

111.4

109.5

0.09

144

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

142

2.26

4.46

2.0

1.8

19.8

186.1

ug/l

0.51

128

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

562

1.61

4.46

1.5

1.4

308.0

287.3

pmol/l

0.26

435

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

149

1045

1.44

4.31

1.7

1.4

1172.0

4595.3

e6/l

0.47

121

837

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

149

1045

1.44

4.31

1.6

1.3

102.5

22.2

e6/l

0.53

116

790

(3009508) Creatinine [Moles/volume] in Urine

1538

13974

1.13

4.30

3.4

3.1

7.7

7.8

mmol/l

0.39

1298

11821

(3027456) Digoxin [Moles/volume] in Serum or Plasma

591

1.58

4.30

2.3

3.1

0.8

nmol/l

0.40

446

(3013727) Leukocytes other/100 leukocytes in Blood

107

2.44

4.29

3.9

2.9

46.3

55.0

1.07

101

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

101

2.48

4.28

1.2

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

167

1197

1.41

4.28

1.5

1.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

279

2165

1.30

4.27

2.4

0.3

e6/l

0.03

270

2095

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.04

4.23

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.04

4.23

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

424

1.68

4.20

1.2

1.1

—

titre

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

404

1.69

4.11

1.2

1.1

—

(3023410) Appearance of Cerebral spinal fluid

483

1.62

4.03

1.9

1.4

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

6.44

3.98

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

253

1.86

3.96

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

520

1.58

3.86

1.7

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

214

1625

1.33

3.86

1.4

9.2

9.6

u/l

0.19

172

1339

(3035933) Granulocytes/100 leukocytes in Blood

139

2.16

3.82

1.6

1.5

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

6.01

3.81

1.1

1.0

—

(37021550) Renin [Units/volume] in Plasma --upright

101

2.38

3.80

1.3

363.0

55.8

mu/l

0.45

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.80

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.84

3.78

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.84

3.78

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.84

3.78

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.84

3.78

1.0

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

8.76

3.77

1.6

2.6

48.3

38.5

umol/l

—

(3047189) Immunofixation for 24 hour Urine

167

2.04

3.74

1.8

—

(3012516) Albumin [Mass/volume] in Urine

1379

12548

1.13

3.71

3.4

3.2

519.3

345.4

mg/l

0.62

882

7803

(3013945) Hepatitis B virus e Ab [Presence] in Serum

4.00

3.69

1.6

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

4.00

3.69

1.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1382

12583

1.13

3.67

1.8

1.6

1.4

mmol/l

1.19

1203

10676

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.38

3.64

1.9

2.4

—

(3036603) Volume of Urine

261

1.81

3.62

1.8

1.5

1389.7

1882.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

210

1608

1.32

3.60

1.9

1.8

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

104

2.31

3.58

1.2

1.1

—

(3004451) EKG impression Narrative

170

2.01

3.58

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

5.30

3.50

1.6

1.8

—

(1761868) Lipid panel - Serum or Plasma

1788

19253

0.90

3.50

2.5

2.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

340

2783

1.23

3.40

1.4

26.1

27.4

iu/l

0.33

297

2402

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.10

3.36

1.2

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

7.01

3.36

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

7.01

3.36

1.1

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.71

3.35

1.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

313

1.70

3.34

1.0

1.1

4.5

0.8

u/ml

0.53

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5063

49522

1.13

3.29

4.3

4.1

4.6

4.7

mmol/l

10.36

4738

46344

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

463

5442

0.84

3.29

1.5

1.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

231

1822

1.28

3.20

1.3

213.3

227.4

miu/ml

0.20

898

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

291

2359

1.25

3.20

2.6

2.2

3070.0

5891.1

u/l

1.36

105

955

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.34

3.19

1.1

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

5.34

3.19

1.0

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

6.37

3.18

1.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

652

1.46

3.18

1.6

1.2

52.3

38.0

u/l

0.36

558

(3034426) Prothrombin time (PT)

158

1.97

3.13

1.2

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.68

3.05

1.2

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

162

1227

1.33

3.05

2.0

1.9

3.9

4.5

iu/l

0.38

471

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

5.01

3.05

1.6

1.8

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.58

3.04

1.7

1.6

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.89

3.02

1.0

1.2

0.0

u/ml

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

5.84

3.02

1.0

1.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.64

2.96

1.3

1.1

122.1

74.0

ng/l

—

(3019977) pH of Arterial blood

198

1.82

2.92

1.8

2.6

7.4

0.18

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

430

3661

1.19

2.91

1.2

93.5

157.6

iu/ml

4.31

130

1365

(4094501)

165

1270

1.31

2.80

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

505

1.49

2.80

1.1

—

73.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.65

2.79

2.2

2.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.24

2.70

1.0

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1424

13191

1.10

2.69

4.3

3.9

10.8

9.3

mg/mmol

0.43

912

8299

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

6.01

2.69

1.0

1.6

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

6.01

2.69

2.0

2.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.50

2.69

3.4

4.7

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

132

1.97

2.69

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1350

12475

1.11

2.68

5.3

4.5

3.0

2.8

ug/l

0.12

1229

11257

(40768795) Lymph node Pathology biopsy report

421

1.53

2.68

1.2

—

(3022475) Manganese [Moles/volume] in Blood

3.13

2.64

1.2

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

183

1.81

2.64

8.6

11.1

—

(4034850)

187

1478

1.27

2.62

12.4

8.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

306

1.61

2.57

2.5

2.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

192

1.78

2.57

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.60

2.57

1.0

1.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

142

1.91

2.55

5.0

6.4

24.3

24.8

mmol/l

0.22

132

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.73

2.54

2.3

1.4

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

190

1512

1.26

2.53

1.6

1.8

40.1

nmol/l

0.00

185

1467

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.16

2.50

1.3

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.16

2.50

1.3

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.16

2.50

1.3

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

143

1.89

2.50

1.3

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

128

969

1.33

2.49

1.9

1.7

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

422

1.50

2.45

2.1

20.0

26.6

ug/l

0.50

415

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.55

2.44

1.0

—

(3006462) Nitrate [Presence] in Urine

226

1.69

2.42

4.0

2.8

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.09

2.42

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

5.00

2.40

1.0

1.1

—

(3011648) Oxygen content in Venous blood

360

1.53

2.39

2.4

2.5

10.1

11.4

1.43

360

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5015

49224

1.11

2.39

4.2

4.0

1.5

mmol/l

2.30

4683

45839

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

2.42

2.36

1.6

1.2

54.5

63.4

—

(3011325) HIV 1+2 Ab [Presence] in Serum

3.64

2.36

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

213

1.69

2.35

1.4

1.7

1.6

3.9

u/field

1.29

152

(40758292) HTLV I+II Ab panel - Serum

2.26

2.34

1.2

1.4

—

(3036670) Protein [Mass/volume] in Synovial fluid

2.18

2.30

1.4

1.2

36.8

37.5

g/l

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

134

1038

1.30

2.24

1.1

1.6

1.7

u/ml

0.03

381

(21494755) Public health laboratory ask at order entry panel

545

6132

0.88

2.24

1.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

136

1056

1.29

2.24

1.8

1.9

201.2

199.5

pmol/l

0.06

130

991

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.10

2.22

1.2

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

2.22

0.0

10.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

157

1.79

2.21

2.4

2.9

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

393

1.48

2.17

1.1

231.4

262.5

mg/l

0.90

349

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

793

0.68

2.17

1.4

7.3

7.1

mmol/l

0.11

587

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

108

1.95

2.15

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.56

2.09

1.0

1.1

—

(4027681)

308

1.53

2.07

1.1

1.2

—

(40757373) Influenza virus identified in Isolate

2.26

2.07

1.4

1.2

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

5.00

2.07

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

5.00

2.07

1.0

1.6

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.91

2.07

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

659

1.36

2.06

1.3

1.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

117

1.88

2.05

1.0

1.1

0.3

2.2

u/ml

0.67

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.50

2.05

1.0

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.50

2.05

8.7

4.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

103

1.94

2.04

1.0

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5108

50268

1.10

2.04

4.6

4.5

2.7

2.8

mmol/l

15.36

4766

46731

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4836

47481

1.09

2.01

3.8

3.6

1.3

mmol/l

2.78

4489

43980

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.82

2.00

1.1

—

(40765096) Chromosome analysis panel by Banding

112

1.88

1.95

1.3

1.1

—

(4281824)

524

0.63

1.95

1.2

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.03

1.95

1.1

0.8

0.7

umol/24h

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

313

1.51

1.95

1.0

0.7

0.6

u/ml

0.13

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

4.55

1.94

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.97

1.93

1.8

2.7

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

127

1.81

1.93

1.2

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.73

1.93

1.4

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.12

1.92

1.3

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

113

1.86

1.91

1.0

1.1

—

(44813793)

323

1.49

1.90

1.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

105

808

1.30

1.90

1.5

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

283

1.52

1.89

1.4

1.3

223.3

347.7

u/l

2.22

270

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

204

1.62

1.88

1.8

2.0

96.4

147.2

umol/l

0.91

105

(3002619) Bacteria identified in Specimen by Culture

2.09

1.86

1.1

1.2

—

(40760410) HLA-B [Type] by High resolution

3.53

1.83

1.0

—

(40763590) HLA-DQ beta [Type]

3.53

1.83

1.0

—

(40760409) HLA-A [Type] by High resolution

3.53

1.83

1.0

—

(46236302) HLA-C [Type] by High resolution typing

3.53

1.83

1.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

120

945

1.28

1.83

1.1

6.9

6.7

u/ml

0.06

472

(4211845)

254

1.54

1.80

4.3

2.7

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.57

1.80

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.76

1.79

3.9

1.9

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

287

1.50

1.78

1.2

1.0

1.1

ratio

0.78

100

(3015076) Soybean IgE Ab [Units/volume] in Serum

287

1.50

1.78

1.0

0.3

2.9

u/ml

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

116

913

1.28

1.78

1.1

2.8

1.1

u/ml

0.40

356

(3013862) HLA-DP [Type]

3.34

1.74

1.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.22

1.73

1.1

1.3

0.8

1.9

mmol/l

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

178

1.63

1.72

1.1

314.9

461.1

ng/l

0.18

(3046861) Legionella sp Ag [Presence] in Urine

3.85

1.71

1.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

118

1.78

1.69

2.0

2.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

118

1.78

1.69

2.0

2.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

175

2098

0.83

1.68

1.5

3.4

mg/l

0.00

131

1438

(3027923) C peptide [Moles/volume] in Serum or Plasma

251

1.52

1.67

1.6

1.5

1.1

1.3

nmol/l

0.40

194

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

120

1494

0.80

1.67

1.5

1.6

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.16

1.66

1.0

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

352

1.42

1.62

3.6

1.7

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

428

1.38

1.61

1.3

10.3

12.4

mmol/l

1.17

(3013139) Helicobacter pylori Ag [Presence] in Stool

373

3306

1.14

1.61

1.2

—

(3000330) Specific gravity of Urine by Test strip

251

2164

1.17

1.59

3.4

3.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

109

866

1.26

1.59

1.1

2.9

1.5

u/ml

0.42

182

(3035880) pH of Pleural fluid

176

1.59

1.54

1.4

1.3

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.34

1.52

1.0

1.2

—

(3000012) Reticulocyte production index

209

1.53

1.50

2.3

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

162

1.61

1.49

1.2

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.95

1.48

1.0

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

136

1120

1.22

1.46

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.22

1.46

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

278

3163

0.87

1.44

1.6

1.5

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

1.92

1.43

6.0

7.5

62.6

71.9

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.73

1.43

1.0

7.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

745

1.27

1.43

1.1

1.0

2.1

2.6

u/ml

0.29

264

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

2.31

1.43

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

177

2077

0.85

1.39

1.5

1.4

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.94

1.38

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

433

0.67

1.37

1.8

1.5

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

1.33

0.0

1.1

—

(3020491) Glucose [Moles/volume] in Blood

367

1.37

1.32

2.2

2.1

7.0

6.3

mmol/l

0.96

258

(1002224) Polysomnography panel

255

2240

1.14

1.31

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.50

1.30

11.8

9.9

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.50

1.30

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

175

0.51

1.28

3.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

175

0.51

1.28

6.2

6.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

138

1.60

1.26

1.1

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

154

1.56

1.25

1.3

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

320

1.38

1.24

1.6

2.0

1.4

1.9

u/field

0.48

124

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

365

3292

1.12

1.24

1.8

—

(3006653) Thiamine [Moles/volume] in Blood

228

1.45

1.23

1.2

131.7

133.6

nmol/l

0.11

228

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

628

1.26

1.21

1.0

0.8

0.3

u/ml

0.58

114

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.16

1.21

1.0

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.31

1.18

7.5

5.7

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.11

1.18

1.8

1.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

457

4183

1.10

1.18

2.0

1.9

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

214

1.45

1.17

2.1

1.8

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

1.16

0.0

1.1

—

8.4

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.50

1.15

1.4

345.4

478.1

nmol/l

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.50

1.15

1.0

1.1

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

2.50

1.15

1.0

0.9

0.4

u/ml

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

103

1.65

1.12

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

413

0.70

1.12

1.0

1.1

—

(4146454)

440

1.30

1.12

2.6

2.7

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.00

1.12

2.1

2.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

295

1.36

1.07

1.0

326.8

325.4

ng/l

0.01

212

(3003694) ABO and Rh group [Type] in Blood

1522

14620

1.05

1.6

1.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

271

1.37

1.04

1.2

1.0

1.1

u/l

0.15

121

(3023430) Cat dander IgE Ab [Units/volume] in Serum

697

1.22

1.03

1.0

1.1

3.9

3.5

u/ml

0.09

252

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.06

1.02

1.4

2.9

0.0

0.6

u/field

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

221

1.40

1.02

1.6

1.8

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.65

1.00

2.6

2.0

9.2

7.5

mmol/l

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

234

2091

1.12

0.98

1.4

1.7

272.0

299.9

mu/l

1.09

222

1881

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.84

0.98

2.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

108

912

1.19

0.98

1.2

—

(3017569) Oxygen content in Arterial blood

156

1.48

0.98

2.0

2.5

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

2.17

0.98

2.6

1.2

8.6

6.5

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.17

0.98

1.0

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

100

1.60

0.96

1.4

1.3

2.7

3.4

mmol/l

0.41

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

293

1.33

0.95

1.0

809.5

747.2

ng/l

0.43

204

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

216

1.39

0.95

1.3

1.1

1.3

10.3

u/ml

—

(4198724)

282

0.67

0.94

1.5

2.8

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

515

1.25

0.94

4.5

4.9

41.9

65.2

u/ml

0.46

148

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.73

0.92

1.1

1.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

295

1.32

0.92

1.0

36.4

44.6

ng/l

0.65

209

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

375

1.28

0.90

1.3

1.5

1.4

nmol/l

0.26

331

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

117

1358

0.86

0.89

2.0

1.8

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.07

0.89

1.0

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

376

1.28

0.89

1.1

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

127

1.50

0.88

1.9

1.8

—

(3001019) Free T4 and TSH panel - Serum or Plasma

348

3201

1.09

0.87

1.7

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

469

0.77

0.84

1.6

8.2

7.7

mmol/l

0.52

293

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.94

0.84

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

327

1.29

0.83

6.1

6.9

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

148

1678

0.88

0.83

1.5

1.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.55

0.81

1.0

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

148

1673

0.88

0.80

1.5

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

148

1672

0.88

0.79

1.5

1.4

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.73

0.79

3.7

3.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

473

1.23

0.79

1.1

1.0

—

(3016244) Insulin [Units/volume] in Serum or Plasma

321

1.28

0.79

3.0

3.3

26.0

32.7

mu/l

0.45

303

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

270

0.70

0.78

1.2

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

357

1.26

0.78

1.1

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

149

1679

0.88

0.77

1.5

1.4

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.77

0.0

1.4

—

29.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.08

0.74

1.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.67

0.74

1.1

1.0

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.67

0.74

8.0

10.1

9.5

6.3

mmol/l

—

(4212803)

1.84

0.73

1.1

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.64

0.73

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.00

0.72

1.2

1.1

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

2.00

0.72

2.6

1.2

52.2

37.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1030

0.86

0.70

2.8

2.3

51.0

98.0

ug/min

1.90

639

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.71

0.70

1.3

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

142

0.63

0.69

1.0

1.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

445

1.22

0.69

4.1

5.2

7.8

7.2

mmol/l

0.52

363

(44806420)

118

0.59

0.67

2.1

2.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

724

1.16

0.67

1.3

1.6

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

232

1.29

0.66

1.1

1.0

94.6

94.4

0.02

183

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

164

1812

0.90

0.64

1.5

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

398

1.21

0.60

1.7

2.2

20.1

19.4

nmol/l

0.23

377

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

103

1163

0.88

0.60

1.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.54

0.59

1.4

1.3

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

210

1.29

0.58

2.1

2.5

58.2

51.6

umol/l

0.52

184

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.58

0.0

3.5

—

(3013762) Body weight Measured

0.00

0.58

0.0

1.2

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.58

0.0

13.8

—

158.5

—

(3005570) Glucose [Moles/volume] in Urine

446

1.19

0.58

1.9

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

276

0.76

0.58

1.0

1.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.71

0.57

1.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

290

2708

1.07

0.57

2.3

3.4

46.9

49.7

u/ml

0.06

279

2614

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.67

0.56

1.0

5.5

10.4

u/l

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

1.51

0.56

1.4

1.2

618.0

492.9

ug/l

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1008

0.88

0.55

4.2

3.0

22.2

25.5

mg/l

0.51

625

(3001556) Androgen free Index in Serum or Plasma

1.52

0.52

1.2

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

250

1.24

0.52

1.2

1.3

18.2

66.6

—

(3042517) Benzodiazepines panel - Urine

1.41

0.51

1.9

2.9

—

(3026470) Cobalt [Mass/volume] in Blood

224

1.25

0.50

1.7

2.1

1.5

3.0

ug/l

2.12

196

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

1.56

0.48

1.1

1.4

77.1

79.7

—

(3005033) Fetal Nuchal fold Thickness US

125

1371

0.91

0.47

1.5

1.4

—

(40768800) Prostate Pathology biopsy report

720

1.13

0.47

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

199

0.75

0.46

1.1

1.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

411

1.17

0.46

1.4

1455.1

2140.5

e6/l

1.19

298

(3037556) Urate [Mass/volume] in Serum or Plasma

103

1.36

0.45

1.4

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

126

1375

0.91

0.44

1.5

1.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.37

0.43

1.2

1.3

—

(3027944) Amphetamines [Presence] in Urine

233

2480

0.94

0.43

1.6

2.2

—

(3045788) Cell count panel - Pleural fluid

321

1.18

0.43

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

130

1414

0.92

0.42

1.6

1.5

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

294

1.19

0.42

1.3

2.8

5.2

umol/l

6.66

276

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.6

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

24.0

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

0.1

—

(3010937) Rubella virus Ab [Presence] in Serum

1.43

0.39

1.0

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

1.43

0.39

1.0

1.1

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.0

—

0.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

215

2024

1.06

0.38

2.0

1.9

—

(3015183) Erythrocyte sedimentation rate

270

1.19

0.38

1.2

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

750

7283

1.03

0.37

3.1

2.8

0.7

ug/l

1.98

480

4538

(3045716) Anion gap in Serum or Plasma

170

1.24

0.37

4.1

2.5

8.7

9.6

mmol/l

0.41

128

(3028308) Erythrocytes [#/volume] in Pleural fluid

375

1.15

0.35

1.4

21686.4

72899.7

e6/l

1.49

223

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

100

919

1.09

0.35

1.5

0.5

0.4

nmol/l

0.38

722

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1023

9998

1.03

0.34

4.3

3.9

20.5

21.8

1.77

453

4483

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

136

1.25

0.33

1.1

1.0

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

803

0.91

0.33

2.5

13.4

13.1

1.56

790

(3041806) Other cells [#/volume] in Blood by Manual count

219

1.19

0.33

1.5

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.67

0.33

14.2

8.1

—

(3019174) dRVVT (LA screen)

1.28

0.32

1.0

1.1

—

(3020650) Glucose [Presence] in Urine

132

0.76

0.32

2.0

1.4

—

(3004775) Volume in Urine collected for unspecified duration

327

0.86

0.31

2.1

645.3

601.9

0.21

223

(44806071)

1.25

0.29

1.3

1.1

—

(3012441) Differential panel - Pleural fluid

335

1.14

0.29

1.6

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

317

1.14

0.28

1.3

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

883

1.08

0.27

1.3

1.4

25.3

u/l

0.01

730

(3017509) Phencyclidine [Presence] in Urine

1.27

0.27

1.4

1.8

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

308

1.14

0.27

1.9

2.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

1041

0.93

0.27

4.1

3.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.21

0.26

1.0

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.25

0.24

1.3

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.25

0.24

2.3

1.8

—

(3011288) Drugs identified in Urine by Screen method

176

1679

1.05

0.24

1.9

3.3

—

(3028300) Cannabinoids [Presence] in Urine

243

2527

0.96

0.24

1.6

2.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

161

1.18

0.24

2.7

2.2

—

(3000764) Benzodiazepines [Presence] in Urine

241

2505

0.96

0.24

1.6

2.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.32

0.23

1.0

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

218

1.15

0.23

1.6

1.7

—

6.9

—

(4133840)

136

0.81

0.23

1.5

1.2

—

(3027008) Opiates [Presence] in Urine

243

2522

0.96

0.23

1.6

2.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.25

0.22

1.0

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

172

1.16

0.22

3.0

2.9

—

(3020618) Glucose [Moles/volume] in Synovial fluid

0.00

0.21

0.0

1.1

—

6.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

409

0.90

0.21

1.8

1.5

1.3

promille

0.04

316

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.0

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

20.6

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

842

0.94

0.20

1.3

2.1

3.7

ug/l

3.56

753

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

6.3

—

0.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

872

0.94

0.20

1.6

—

(40768806) Pleura Pathology biopsy report

345

1.10

0.20

1.6

1.5

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.22

0.20

1.2

1.1

—

(3000285) Sodium [Moles/volume] in Blood

1.20

0.19

1.2

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

735

1.06

0.18

4.2

5.4

299.8

371.8

umol/l

5.04

640

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

100

1.20

0.18

11.1

7.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

406

1.08

0.17

1.4

64.0

140.1

pmol/l

0.51

126

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.15

0.17

1.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

138

1.16

0.17

2.3

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.13

0.17

3.7

1.5

128.0

110.6

ng/l

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.71

0.16

9.0

8.5

—

(3024869) Neuronal Ab [Presence] in Serum

1.18

0.16

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.77

0.15

2.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

328

0.91

0.15

2.4

1.6

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.14

0.15

1.2

1.5

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

1.14

0.15

1.4

17.9

22.6

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

307

0.91

0.15

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

614

6046

1.02

0.14

1.7

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.81

0.14

1.3

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.82

0.13

1.3

1.8

—

(3000034) Microalbumin [Mass/volume] in Urine

433

1.06

0.12

4.5

2.9

35.7

54.6

mg/l

0.36

327

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.18

0.12

1.2

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

191

1865

1.02

0.11

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

104

1074

0.97

0.10

1.8

3.2

—

(40768793) Breast Pathology biopsy report

121

1175

1.03

0.10

1.3

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.11

0.09

1.0

1.1

2.1

1.6

umol/24h

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

451

1.04

0.07

2.8

2.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.86

0.07

1.1

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

118

1.10

0.07

1.3

2.2

16.0

15.3

umol/l

0.14

118

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

802

0.97

0.07

1.1

27.9

11782.8

iu/ml

—

206

(3044242) Glucose [Moles/volume] in Arterial blood

187

1.07

0.06

2.0

2.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

935

0.98

0.03

1.7

2.1

0.9

0.8

nmol/l

0.48

794

(1001926) Buprenorphine [Presence] in Urine by Screen method

191

1927

0.99

0.03

1.6

2.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.09

0.03

1.8

1.3

—

(3016879) Cocaine [Presence] in Urine

230

2311

1.00

0.01

1.6

2.3

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

118

1.02

0.00

1.7

2.5

93.9

137.1

ng/l

—

(3016750) Collection duration of Urine

228

1.01

0.00

2.3

2.0

503.5

493.6

min

0.18

176

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

134

0.97

0.00

1.8

2.0

12372.6

22949.4

e6/l

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

156

1.03

0.00

1.8

2.1

559.2

871.8

e6/l

—

115

(3033799) Differential panel - Peritoneal fluid

127

1.02

0.00

2.2

2.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

596

5955

1.00

0.00

1.8

—

(3044007) Cell count panel - Peritoneal fluid

131

0.99

0.00

1.6

2.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

349

1.00

0.00

1.7

1.6

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.2

—

2615.3

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.0

5.7

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

1.8

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.2

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.0

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.0

2.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

740

1.00

0.00

1.2

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

0.0

1.0

—

(3003771) Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

1.0

—

85.3

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

0.85

0.00

3.0

4.2

41.5

39.6

umol/l

—

(3028717) Thiamine [Mass/volume] in Blood

1.00

0.00

1.0

1.3

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: RX_A07EA – Budesonide

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Budesonide

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Budesonide (RX_A07EA)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints